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Abstract 
 
Cardiolipin is a unique four-tailed pH-responsive lipid found in the mitochondria of animals 
and in the membranes of bacteria.  It has been found to play a role in altering numerous 
physicochemical properties of bacterial membrane mimics including membrane fluidity, 
mechanical stability, and thermotropic behaviour, and it is also unique in that its two 
headgroups have different pKa values (~2.8 and 7.5-9.5), allowing cardiolipin to be either 
uncharged, or carry one or two negative charges.  However, despite these properties there is 
still relatively little research on its specific function and role in shaping the self-assembly and 
phase behaviour of bacterial membranes and the response of these membranes to their 
environment.  In light of the rising need for novel strategies for targeting bacteria due to 
antibiotic resistance, cardiolipin is an important target for investigation in order to gain a 
deeper understanding of the bacterial membrane and how it can be disrupted. 
 This project aimed to investigate the effects of cardiolipin and pH on the properties of 
bacterial membrane mimics, specifically the phase behaviour of mesophases and the stability 
of liposomes, two models for bacterial membranes.  High-pressure small-angle x-ray 
scattering (HP-SAXS) was used to construct pressure temperature phase diagrams of 
mesophases consisting of 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) and 1,2-
dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DOPG) in a 78:22 ratio, and DOPE, DOPG and 
18:1 cardiolipin in a 70:20:10 ratio, mimicking the membrane of E. coli., at pH 1.3, 5.1 and 
12.1.  Both cardiolipin and pH were found to have an impact on the phase behaviour of the 
system, with the HII phase forming under ambient conditions at pH 1.3 and the Lα phase 
forming at pH 5.1 and 12.1.  Cardiolipin was found to have an effect on the behaviour of the 
system, increasing the sensitivity of the coherence length L to temperature, increasing the d-
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spacing at all temperatures studied at pH 5.1, and increasing the dependence of d-spacing on 
pressure at pH 5.1.  DOPE/DOPG and DOPE/DOPG/CL liposomes were also used to model the 
E. coli membrane at pH 5.1 and 12.1 and, where cardiolipin and pH were also found to have 
an effect on the properties of the liposomes.  The cardiolipin-containing liposomes did not 
undergo any significant change in average diameter D or zeta potential ζ between pH 5.1 and 
12.1, while the DOPE/DOPG liposomes had both a lower D and ζ at pH 12.1 than at pH 5.1, 
pointing to a definite role of cardiolipin in mediating the response of the lipids to pH.   
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Chapter 1. Introduction 
 
1.1 Project Motivation 
Antibiotic resistance is a growing global issue.  Bacterial infections are predicted to cause an 
increasing number of deaths over the 21st century as current antibiotics becomes obsolete, 
making it clear that alternative strategies for killing bacteria need to be developed.  As the 
bacterial membrane is an essential component of the cell and the interface through which 
they interact with their environment and antibiotic drugs, it is of fundamental importance to 
understand how and why bacterial membranes behave under differing solution conditions 
such as pH, temperature and ion concentration. 
Cardiolipin is a unique four-tailed lipid present in an enormous array of prokaryotic 
and eukaryotic species that makes up a significant proportion of bacterial membranes, 
typically around 10%. It has been demonstrated to have a significant impact on the 
physicochemical properties of lipid membranes, affecting their thermotropic behaviour, 
promoting the formation of non-lamellar structures, increasing membrane fluidity, and 
decreasing membrane mechanical stability.1-3  However, at the time of writing no pressure-
temperature phase diagram had previously been established for a cardiolipin-containing 
bacterial membrane model.  Constructing a phase diagram would provide an overview of the 
effect of cardiolipin on the response of a bacterial membrane model to pressure and 
temperature.  There have also been few studies examining the effect of pH on cardiolipin in 
the context of the behaviour of bacterial membrane models.   
Cardiolipin is interesting not just because of its previously established impact on lipid 
membrane properties, but also due to its pH responsiveness.  It is unique in that it contains 
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two phosphate headgroups and four carbon tails, and it has been demonstrated 
experimentally that these two headgroups have differing pKa values (approx. 2.8 and 7.5-9.5, 
respectively),4 likely due to intramolecular bonding between the glycerol linker present and 
one of the headgroups.  It carries a single negative charge at physiological pH; however, as 
the pH decreases, the repulsion between the headgroups is minimised as both headgroups 
are protonated.  It seems likely that changes in head group repulsion could affect the packing 
parameter and therefore the self-assembly behaviour of cardiolipin, and so obtaining phase 
diagrams under different pH conditions would provide further insight into the role cardiolipin 
is playing in bacteria. 
In this project, the phase behaviour of mesophases mimicking the composition of 
bacterial membranes (i.e. the DOPE:DOPG:CL molar ratio at 70:20:10) has been studied via 
small-angle X-ray scattering (SAXS) at different pH values at Diamond Light Source beamline 
I22 with the aim to produce pressure-temperature phase diagrams for this system at different 
pH values.  Polarised light microscopy (PLM) images of these mesophases were also obtained 
in order to complement the SAXS findings, and dynamic light scattering (DLS) measurements 
of liposomes - another model mimicking the bacterial membrane - of the same lipid 
composition were carried out at different pH values to assess the effect of cardiolipin on the 
stability of the liposomes over time. 
A greater understanding of the role of cardiolipin in the behaviour of bacterial 
membranes would contribute to the overall understanding of how bacterial membranes 
respond to their environment and maintain structural integrity, with a view to better 
understand how to physically disrupt bacterial membranes in light of the growing global issue 
of bacterial antibiotic resistance.  Chapter 1 of this thesis introduces the context of antibiotic 
resistance and introduces cardiolipin and its properties, and how cardiolipin is relevant to this 
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challenge.  It also introduces the concept of self-assembly and lipid mesophases and how they 
are useful for gaining insight into bacterial membranes.  Chapter 2 describes the experimental 
details of the project, introducing the techniques used and detailing how experiments were 
conducted.  Chapter 3 presents the results of the SAXS experiments and their discussion, 
while Chapters 4 and 5 cover the DLS and PLM results respectively, before conclusions and 
future work in Chapter 6. 
 
1.2 Antibiotic Resistance 
With the discovery of penicillin in 1928, medicine entered a new era wherein previously life-
threatening infections became treatable. It also greatly improved the outcomes for the 
immunocompromised, allowing for treatments such as chemotherapy and organ 
transplants.5 The ability to effectively treat infections through the use of naturally and then 
later synthetically-derived compounds saved countless lives across the 20th century and 
continues to be a key tool in modern medicine in the 21st; however, this ability is now under 
threat.  Even at the dawn of the antibiotic era in 1945, Alexander Fleming, the discoverer of 
penicillin, warned of the possibility of bacteria developing resistance in his Nobel Lecture: “It 
is not difficult to make microbes resistant to penicillin in the laboratory by exposing them to 
concentrations not sufficient to kill them, and the same thing has occasionally happened in 
the body”.6  These fears would be confirmed in 1947 with the observation of penicillin-
resistance in staphylococcus pyogenes, the author stating that “the rate of increase in this 
hospital at present is so rapid as to be somewhat alarming”.7 
Since then, resistance to subsequently discovered antibiotics has continually 
developed with methicillin-resistant staphylococcus aureus (MRSA) being identified in 1961- 
two years after the introduction of methicillin; levofloxacin-resistant pneumococcus emerged 
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in 1996, the same year that levofloxacin was introduced; and ceftaroline-resistant 
staphylococcus aureus was found in 2011, with ceftaroline having been introduced in 2010.8 
It is clear that antibiotic resistance in bacteria is a growing issue. 
In 2015, there were an estimated 671,689 infections and 33,110 deaths in the EU and 
European Economic Area as a result of antibiotic resistant bacteria,9 while in the USA there 
are estimated to be at least 2 million such infections every year with approximately 23,000 
resultant deaths.10  The prevalence of multidrug resistant bacteria has been growing 
worldwide at a rapid rate, reaching pandemic levels in the past two decades,10 with 10 million 
lives projected to be at risk every year by 2050.11 This makes clear the scale of the issue - 
especially as the burden of antibiotic resistant bacteria is highest in babies and the elderly in 
the EU and EEA, indicating that with an ageing population the threat will only increase.12 
Alongside the rapid increase in the rates of resistance, there is also a ‘discovery gap’ 
in research wherein very few new antibiotic drugs are being discovered and approved for use, 
while resistance against existing drugs continues to rise: between 2005 and 2009, only one 
new drug – telavancin - was approved by the FDA.13  At the same time, antibiotics continue 
to be prescribed inappropriately, which contributes to the development of resistance,14 as 
well as being used in veterinary settings and as herbicides and pesticides,15 making the 
preservation of their efficacy a challenge. 
There are multiple mechanisms through which bacteria can become resistant to 
antibiotics.  Some have inherent resistance to certain drugs, such as the inherent resistance 
of gram-negative bacteria to many hydrophobic bacteria owing to the structure of their outer 
membrane.16  In addition to the case described by Fleming17 wherein treatment kills all 
bacteria except those with inherent resistance which then go on to proliferate, bacteria can 
acquire resistance through horizontal gene transfer via bacteriophages, plasmids or even 
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naked DNA (even between bacteria of different taxonomic groups)18 or undergo spontaneous 
mutations that grant them resistance.19  Even so-called ‘last resort’ antibiotics such as 
vancomycin, used to treat methicillin-resistant Staphylococcus aureus (MRSA) which emerged 
in 1961, are not guaranteed to remain effective indefinitely; in recent years, vancomycin-
intermediate S. aureus  has emerged worldwide, one of many multidrug- or even pan-
resistant species.20 
The antibiotics discovered in the ‘golden age’ of discovery in the mid-20th century 
were almost all found within nature rather than being produced synthetically.  However, this 
eventually led to drugs within the same class being ‘re-discovered’ and an insufficient number 
of new classes being discovered to keep up with developing resistance.  Furthermore, modern 
antibiotic discovery techniques employed by the pharmaceutical industry since the 1990s 
such as high-throughput screening have failed to yield significant results.21  It is clear that, 
with the seeming inevitability of the development of resistance to conventional antibiotics, 
there is a necessity for the exploration of alternative strategies to combat bacteria. 
There have been several proposed and trialed alternatives to conventional drugs, 
including antibody therapy,22 and phage therapy;23 however, neither have seen wider 
application in a medical context.  While there has been an effort to reduce the rate at which 
resistance develops to currently used antibiotics through the endorsement of conservative 
and appropriate use, this is not a strategy that can be counted on to work in the long-term.   
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1.3 Introduction to Lipids 
Lipids are a class of amphiphilic biomolecules ubiquitous throughout nature.  Amphiphiles are 
molecules that contain both a hydrophobic and a hydrophilic moiety, and as a result are often 
soluble in both aqueous and non-aqueous solutions.  In the case of lipids, which are soluble 
in non-polar solvents but not as soluble in water, the hydrophobic moiety consists of fatty 
acid chains or tails, with both unsaturated chains and saturated chains containing one or more 
double or triple bonds being present in various species of lipid.    Thousands of distinct species 
have been identified in nature24, with a variety of different headgroups, chain lengths and 
degrees of saturation available.  Chain lengths of 12-20 C are common, while a large range of 
head groups occur including glycerol, choline, serine and inositol.25 There are eight classes of 
 
Fig. 1. Common phospholipids with tail groups and headgroups indicated. 
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naturally occurring lipids: sphingolipids which have roles in the regulation of various cell 
processes such as the cell cycle and apoptosis,26 glycerolipids, glycerophospholipids, sterol 
lipids, phenol lipid, saccharolipids, and polyketides.27  They perform a wide range of biological 
functions,  including energy storage, thermal insulation, signaling, and protecting organs from 
damage.  
Phospholipids are defined by the inclusion of a phosphate head group on the linker, 
and typically have two fatty acid tails.  Some phospholipids commonly found in bacteria 
include 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), 1,2-dioleoyl-sn-glycero-3-
phospho-(1'-rac-glycerol) (DOPG), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine 
(POPE), and 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1’-rac-glycerol) (POPG) (figure 1).  
Phospholipids are notable for being the main component of cell membranes due to 
their amphiphilic nature, and they self-assemble into a variety of structures in both aqueous 
and non-aqueous solvents, this being a key feature and essential for life.  The formation of 
bilayers and vesicles allows for the protection of the internal environment of cells and 
provides a semi-permeable barrier through which ions and essential nutrients can pass.  
Phospholipids are a constant feature throughout nature, and the composition of lipids 
present in membranes varies greatly between species and is sensitive to external conditions 
including pH, temperature, cellular age, availability of nutrients and the presence of 
pathogens, pointing to their vital and dynamic role in the maintenance of life.25 
Examples of these qualities include the fact that halophilic and halotolerant bacteria 
that thrive at high salt concentrations typically contain a larger proportion of anionic lipids 
compared to non-halophilic species, an adaptation to minimise membrane stress in such an 
environment,28 and that temperature has also been found to have an effect on the PE, PG and 
cardiolipin content of various species of bacteria, such as bacillus caldotenax29 and 
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neurospora crassa,30 pointing to the importance of variations and changes in lipid 
composition in the adaptation of organisms to their surroundings and the necessity of the 
variety of lipids in nature. 
 
1.4 Introduction to Self-assembly 
As previously mentioned, phospholipids are amphiphilic in nature and contain both a 
hydrophobic and a hydrophilic moiety.  When placed into an aqueous solution, they are 
subject to the hydrophobic effect, the effect wherein hydrophobic molecules aggregate to 
minimise their contact with the water, resulting in the formation of self-assembled structures. 
When a non-polar substance is present in water, it disrupts the 3-dimensional 
hydrogen bonding network that exists between the water molecules, causing them to re-
orientate around the hydrophobic molecules to maximise their intramolecular hydrogen 
bonding and causing a decrease in entropy,31 a phenomenon known as the hydrophobic 
effect.  At the same time, the hydrophobic molecules aggregate in order to maximise their 
contact with each other and minimise their contact with the water in order to afford an 
increase in entropy. 
In amphiphiles, the molecules are subject to both the hydrophobic effect arising from 
the fatty acid chains, and the favourability of the interactions between the hydrophilic head 
groups and the aqueous solvent.  As a result, they self-assemble into structures that best 
satisfy these opposing forces, where an optimal surface area per head group and therefore a 
minimum free energy per molecule is obtained.  In addition, the exact structure formed is 
influenced by geometric constraints which prevent multiple-chained lipids being able to form 
micelles and entropic constraints which prevent single-chained lipids from being able to form 
vesicles and bilayers.32 
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The thermodynamics of the formation of micelles is described by equation 1, 
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Equation 1 
 
where 𝜇𝑁
0  is the free energy per molecule in the micelle, 𝑘 is the Boltzmann constant, 𝑁 =
1 corresponds to isolated molecules or monomers in solution, 𝑇 is the temperature, 𝑋𝑁 is the 
mol fraction of molecules incorporated into micelles of aggregation number 𝑀, and is an 
arbitrary reference state of micelles with aggregation number 𝑀.  When  𝜇𝑀
0 = 𝜇𝑁
0 , the 
monomer state is preferred as it is entropically favoured.  For aggregation to occur, it must 
be accompanied by a negative change in free energy.32 
The free energy change associated with aggregation from a dilute monomer state can 
be modelled equation 2, 
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Equation 2 
with the first term being the negative free energy contribution resulting from the tails coming 
into contact with one another, a favourable interaction compared to contact with water; the 
second term being a positive free energy contribution to reflect the fact that the tails are 
never completely out of contact with water; and the third term being another positive energy 
contribution reflecting the electrostatic and/or steric repulsion between the head groups as 
the monomers pack together closely.33 
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Furthermore, the geometric factors involved in self-assembly have been described. 
The geometric constraints can be quantified and the equilibrium structure predicted using 
the packing parameter, first described by Israelachvili, Mitchell and Ninham in 1975, 
 𝑃𝑎𝑐𝑘𝑖𝑛𝑔 𝑝𝑎𝑟𝑎𝑚𝑒𝑡𝑒𝑟 =  
𝑣
𝑎0𝑙𝑐
 Equation 3 
where 𝑎0 is the optimal area per amphiphile, 𝑣 is the volume of the lipid, and 𝑙𝑐 is the length 
of the hydrocarbon chains. 
In a spherical micelle, the radius 𝑅, 𝑣 and 𝑎 at the interface between the hydrocarbon 
chains and water are related by equation 4: 
 𝑅 =
3𝑣
𝑎
 Equation 4 
The radius of the molecule cannot exceed 𝑙𝑐, and so 
𝑣
𝑎0𝑙𝑐
  must be less than or equal to 1/3 for 
micelles to form unless surface area 𝑎 > 𝑎0.  When 
𝑣
𝑎0𝑙𝑐
  exceeds 1/3, alternative structures 
will form, summarised in table 1.  When the packing parameter is equal to or less than 1/3, 
micelles form; however, between 1/3 and 1/2, cylindrical micelles are formed, followed by 
vesicles and flexible bilayers as the packing parameter reaches 1/2 and the space occupied by 
the lipids takes on a truncated cone shape.  When the packing parameter reaches 1 and the  
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space occupied by the lipids becomes cylindrical, planar bilayers form, followed by an  
increasing tendency to form inverted phases as the packing parameter increases beyond 1.34 
 
  
 
 
Surfactant Shape 
 
Packing Parameter 
 
Shapes Formed 
  
< ⅓ 
  
  
⅓ - ½  
  
  
½ - 1 
 
  
1 
 
  
> 1 
 
Table 1. Lipid structures and mesophases formed according to packing parameter. 
Spherical 
micelles 
Cylindrical 
micelles 
Flexible 
bilayers and 
vesicles 
Planar 
bilayers 
Inverted 
hexagonal 
phase 
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1.5 The Cell Membrane as a Target 
Lipid membranes are a universal feature of all types of cell, including bacteria.  They play an 
essential function in maintaining the structure of the cell, acting as a protective semi-
permeable barrier, allowing for the maintenance of concentration gradients essential to life, 
intracellular communication and recognition, adhesion to surfaces, and other specialised 
functions.35  Because the cell membrane is the barrier between the inner workings of the cell 
and an often changing outside environment, and the interface through which it interacts with 
its surroundings, its integrity is essential to the survival of the cell, and necessary for the 
existence of cellular-based life. 
The basic composition of a cell membrane is a double layer of phospholipids that 
supports embedded cholesterol and proteins that carry out functions such as transport of 
ions and substrates, intercellular communication and cell recognition.  Many proteins also 
bind to the cell membrane in a reversible electrostatic or hydrophobic manner, often 
requiring the presence of anionic lipids, and smaller species can diffuse through the lipid 
membrane directly without the use of proteins.36 
However, bacteria differ significantly from eukaryotic organisms beyond this basic 
structure. In addition to a cell membrane, bacteria also have a second polysaccharide and 
peptidoglycan outer membrane or cell wall (Fig. 3).37  Between these two layers is the 
periplasmic space which contains a range of ions and proteins that are necessary for and 
facilitate essential cell processes such as electron transport and hydrolysis of substrates.38  
The major lipid species found in bacteria are phosphatidylglycerol (PG, anionic), 
phosphatidylethanolamine (PE, zwitterionic) and cardiolpin (anionic), with cardiolipin found 
to form domains within bacterial membranes and PG hypothesised to do the same.36 
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The composition of bacterial membranes varies between species but can be sorted 
into two main categories: gram-negative and gram-positive.  Gram-negative bacteria include 
species such as and have an outer membrane where the inner leaflet is composed of 
phospholipids and the outer membrane is composed of lipopolysaccharides (LPS).38  The LPS 
layer also contains magnesium and calcium ions that help maintain its integrity through the 
bridging of negative charges present on the phosphate groups of the sugars.39  Gram-positive 
bacteria on the other hand do not have a second lipid bilayer, and instead have a wall 
comprised of peptidoglycan that is around 40-80 nm thick, and the periplasmic space is much 
larger than in gram-negative bacteria.40  Another difference between the two classes of 
bacteria is the general lipid composition, with gram-positive bacteria containing a larger 
proportion of negatively-charged PG, and gram-negative bacteria containing a larger 
proportion of zwitterionic PE lipids.38 
Most conventional antibiotics need to cross the bacterial membrane in order to take 
effect, as they work by inhibiting the production of proteins, RNA or DNA.41  The most 
commercially and medically successful antibiotics include 𝛽-lactams, fluoroquinones, 
rifampicins and tetracyclines, whose targets are enzymes involved in essential cell processes, 
Fig. 3.  Diagram of a gram-negative bacteria cell envelope (taken from reference 37) 
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DNA processes, or RNA translation respectively.42  As all these processes occur within the 
bacterial cell itself, it is clear that a necessary feature for many antibiotic drugs is the ability 
to penetrate the bacterial membrane. It has been found that interactions between drugs and 
lipids have a significant role in shaping key pharmacokinetic properties of drugs including their 
distribution and accumulation.43  Some naturally occurring compounds found to have 
antimicrobial activity are thought to work through disruption or alteration of the bacterial 
membrane including sesquiterpenes and epigallocatchetin gallate, as well as some developed 
antibiotics such as dalbavancin,19 while the use of liposomes to enhance drug delivery also 
relies upon the interactions between the vesicles and the bacterial cell membranes.44 
In addition, a variety of bactericidal surfaces that kill bacteria mechanically using 
nanostructures exist in nature and can be produced artificially.  These structures can include 
nanospikes, nanopores and nanopillars, and can both prevent bacterial adhesion and rupture 
bacterial membranes upon contact,45 an example being the nanopillar-covered wings of 
cicadas, which while not able to prevent bacterial adhesion, were found to penetrate all P. 
aeruginosa cells that they came into contact with, and so are highly effective at killing them.46  
Antimicrobial peptides that are thought to physically damage bacterial membranes are also 
widespread throughout nature, and as their bactericidal ability takes advantage of the 
structure of the bacterial membrane itself, in order to develop resistance, bacteria would 
have to develop a new membrane structure.  Any strategy that targets the bacterial 
membrane itself may be able to take advantage of the fact that the development of resistance 
would require the bacteria to re-organise or change the composition of its membrane, a costly 
strategy,39 and so may be a valuable route to explore for developing new ways to target 
bacteria. 
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1.6 Introduction to Cardiolipin 
Cardiolipin (CL) (Fig. 4) is an anionic phospholipid found in the membranes of both prokaryotic 
and eukaryotic species.47  The name ‘cardiolipin’ derives from the fact that the discovery of 
this lipid was first reported in 1942,48 isolated from beef heart cells, where it was found to be 
an important component of the inner mitochondrial membrane that is essential for optimal 
functioning.  Alterations in the cardiolipin content or in the acyl chain content of cardiolipin 
is associated with various dysfunctions and diseases including Barth syndrome, heart failure, 
hypothyroidism and ischemia,49 and it has been found to play a role in orientating membrane 
proteins, receptors and enzymes.50  It has been found that several proteins involved in 
oxidative phosphorylation incorporate cardiolipin into their quaternary structure, and cannot 
function without its presence.51  It has also been identified in the structures of various 
bacterial proteins such as succinate dehydrogenase in E. coli.52 
In bacterial membranes, cardiolipin commonly comprises around 10% of the total 
membrane lipid,47, 53-55 although it has been observed in some species of bacteria including E. 
coli and S. aureus that this proportion increases in response to environmental stress,56, 57 as 
well as during the stationary phase of growth (when the number of bacteria in a population 
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remains stationary, commonly due to a limiting environmental factor such as the availability 
of an essential nutrient).58, 59  For example, it was found by Romantsov et al. that E. coli grown 
in high-salinity conditions the proportion of CL increased while the PE content decreased, at 
least partly due to the osmotic induction of the CL synthase gene.  The CL/PG ratio was also 
found to be more than two times higher in the cytoplasmic membrane than in the outer 
membrane: 0.20 vs 0.09.60  It is possible that this increase in the CL content in response to 
stress may indicate that CL plays a role in enhancing the structural integrity of bacterial 
membranes.47 
Cardiolipin has an unusual molecular structure, consisting of two phosphate head 
groups joined by a glycerol linker, and, unlike most membrane lipids, it has four carbon tails, 
two per head group.  Due to this bulky structure, it has a restricted degree of mobility and 
conformational flexibility and a low capacity for self-shielding, and therefore its head groups 
are generally more accessible for interactions with drugs, ions, and water compared to most 
other lipids.47  Cardiolipin also has a very small head group area relative to its fatty acid tails, 
comparable to two typical lipid molecules sharing a single head group, which should promote 
cohesion between the fatty acid chains.47  Its packing parameter is greater than one, 
indicating its preference for an inverse curvature and the formation of the inverted hexagonal 
HII phase, suggesting that the incorporation of cardiolipin into lipid membranes may increase 
their propensity for negative curvatures.  This effect has been observed in nature, where 
cardiolipin has been found to exist in greater concentrations in curved regions of the bacterial 
membrane such as the poles and septum regions.60 
It is clear that cardiolipin plays a physiological role in membranes. However, the role 
it plays in shaping the physicochemical properties of membranes is not entirely clear, and as 
it is so commonly found in bacteria and makes up a significant portion of the membrane, 
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understanding its role is very relevant to understanding the behaviour and properties of 
bacterial membranes in general. 
Previous studies of the effect of cardiolipin on lipid membranes have shown that 
cardiolipin plays a role in shaping their physicochemical properties, decreasing the water 
permeability of vesicles when present in even small amounts.  In a paper by Nichols-Smith et 
al., giant vesicles were prepared with compositions of 99.5% SOPC/0.5% POPS or SOPS, 95% 
SOPC/5% CL, and 90.8% SOPC/9.2% CL.  Compressibility experiments were carried out using 
the micropipette technique wherein changes in membrane tension are related to vesicle 
surface area.  Surface pressure-average area isotherms were also obtained for mixed egg 
PC/cardiolipin monolayers, and it was found that on a pure water subphase a mixture of 40% 
CL/60% egg PC was the most stable, while on a salt subphase this occurs at 60% CL.  Cardiolipin 
appears to decrease the apparent area compressibility modulus and the lysis tension of 
bilayer structures, suggesting that cardiolipin decreases the lateral tension between 
monolayer leaflets and lowers the energy required the stretch the membrane.61 
Wydro found that cardiolipin has also been found to weaken interactions between 
molecules in mixed POPE/POPG/CL and POPE/DPPG/CL films following pressure-area 
isotherms obtained on a pure water and a 15mM NaCl subphase.  It is proposed that this may 
be due to cardiolipin’s large bulk, disturbing the system and disrupting packing, thereby 
weakening intermolecular interactions.62  In another study by Etienne et al., GIXD was used 
to investigate DPPC/CL monolayers and it was demonstrated that the presence of CL 
increased the lateral pressure in the acyl chain region, which could affect the way that the 
membrane interacts with proteins such as by facilitating the anchoring of proteins or affecting 
the structure of membrane proteins.63  Cardiolipin was also observed by Unsay et al. using 
confocal microscopy, fluorescence correlation spectroscopy and atomic force microscopy to 
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increase the fluidity and decrease the mechanical stability in planar supported bilayers when 
present at 5, 10, and 20% with egg PC, and a mitochondrial membrane mimic composed of 
egg-PC:PE:PI:PS:CL at 48.5:27.2:9.9:10.0:4.4 mol.1 
Cardiolipin’s effects on membrane properties can be observed in mitochondria, where 
it is found in mammals- it has been observed by Ohtsuka et al. that Chinese hamster ovary 
cells with a CL content 30% of the normal value showed lacking and disorganised cristae, 
suggesting that CL may play an important role in regulating the curvature of the membrane.64 
 
1.7 The pH Responsiveness of Cardiolipin 
As well as its unusual structure and restricted conformational flexibility, a key property of 
cardiolipin is its responsiveness to pH and the subsequent consequences for its behaviour 
within membranes.  Cardiolipin’s two headgroups are diastereotopically inequivalent,65 being 
esterified at the 1- and 3- positions of the head group glycerol respectively.  This is a possible 
explanation for the observation that cardiolipin’s two head groups have very different pKa 
values- approximately 2.8 and 7.5-9.5 respectively,66 carrying two negative charges at very 
basic pH, one negative charge at physiological pH with a single proton trapped in a bicyclic 
resonance structure (Fig. 5)  and no negative charge at acidic pH.  However, it has also been 
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suggested that these two pKa values may be the result of an intramolecular hydrogen bond 
between the proton present on the glycerol head group and one of the phosphate moieties.67 
These two differing pKa values grant cardiolipin the ability to act as a buffer and a 
proton sink,68 and also mean that its properties are to be pH-dependant.  At basic pH when 
both head groups are negatively charged, the repulsion between the two head groups is 
maximised, leading to a slightly more cylindrical shape.  Likewise, when both head groups are 
protonated, the tails are freer to move around, and the molecule can adopt an inverted 
truncated cone shape.69  This effect has been observed both experimentally70 and 
computationally,71 with cardiolipin’s propensity to form inverted phases being maximal at a 
neutral charge.  This points to there being consequences for the behaviour of the lipid 
membranes that contain cardiolipin, affecting the packing and organisation of the molecules 
within the membrane and therefore the phase behaviour.68  And so, investigating and 
understanding the effect is also of vital importance for fully understanding the fundamental 
impact of cardiolipin within membranes. 
This effect has been observed by Khalifat et al., where microinjections of HCl solution 
delivered to the outside of giant unilamellar vesicles (GUVs) containing cardiolipin caused 
morphological changes reminiscent of cristae in mitochondria, caused by tighter packing and 
increased elastic stress at the outer membrane resulting in the observed morphology.  The 
vesicles were composed of PC/PE/CL in a ratio of 60:30:10, representative of a biological 
membrane. The same effect was not observed in GUVs composed of only PE/PC 66:34, 
highlighting the role of cardiolipin in this responsiveness to pH.72  However, little research has 
been done regarding the effect of pH on cardiolipin-containing membranes that specifically 
aim to model bacterial membranes, and this information would be valuable in better 
33 
 
understanding how certain bacteria tolerate extreme pH environments, and gaining a deeper 
fundamental understanding of the role CL plays in the survival of bacteria. 
 
1.8 Lipid Mesophases 
Lipids are able to self-assemble into a wide range of structures including but not limited to 
micelles, vesicles and bilayers, known as mesophases- states that are intermediate between 
liquid and solid.  Bilayers themselves can exist in a variety of phases (Fig. 6) such as the L𝛼 or 
fluid phase, which is most ubiquitous in biology as it allows for the maintenance of structural 
integrity as well as function.73  In the Lα phase, the tail groups are disordered and move more 
freely than in other bilayer phases.  Bilayers can also exist in the Lβ or Lβ’ gel phase.  In this 
phase, lipid tails are more ordered and organised either perpendicular to the plane of the 
bilayer in the Lβ phase or at a tilt in the L β’ phase.  The Lc phase occurs at low temperatures 
and is the phase in which the lipid tails are the most highly ordered.  During some phase 
transitions there also exists a pretransition P β’ rippled phase as the chains melt from the Lβ to 
the Lα phase, although this is only known to occur in bilayers containing PC.74 
Beyond bilayers, hexagonal and cubic phases can also form.  The hexagonal phases 
consist of micellar columns packed into a hexagonal lattice, with the water channels either 
between the columns in the case of the HI phase where there is positive curvature with 
 
Fig. 6. The structure of the Lα, Lβ and LC bilayer phases 
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respect to the lipid chain region, or water channels within the columns in the case of the HII 
phase where there is negative curvature with respect to the chains i.e. the tails protrude 
outwards.75 Bicontinuous cubic phases are periodic three-dimensional structures consisting 
of curved bilayers and water channels with a regular structure, sponge phases are similar to 
bicontinuous cubic phases, however they have a disordered structure and are more fluid.75 
The mesophases formed by a particular lipid or mixture of lipids depends on a range 
of factors including pressure, temperature, pH, ion concentration and hydration, and 
transitions between different phases can be induced by altering these factors and the phase 
behaviour of a lipid or lipid mixture can be illustrated through phase diagrams, such as 
temperature-pressure or temperature vs hydration. 
 
1.9 Introduction to Liposomes 
Liposomes are a structure commonly formed by the self-assembly of lipids.  They are spherical 
vesicles surrounding an aqueous core, and may be classified according to their size and the 
number of layers they contain.  Unilamellar vesicles (ULVs) consist of only one layer of bilayer 
and can be further classified according to size- small unilamellar vesicles (SUVs), large 
unilamellar vesicles (LUVs), and giant unilamellar vesicles (GUVs)- while multilamellar vesicles 
(MLVs) consist of multiple layers of bilayer separated by thin layers of water.  Liposomes can 
vary in size from 0.025 - 2.5 𝜇m,76 with SUVs being less than 1 𝜇m in size, LUVs being 0.1 - 1.0 
𝜇m, and MLVs can reach over 500 𝜇m and contain hundreds of layers.77 
Liposomes can be tuned to carry out specific functions by adjusting their lipid 
composition to influence properties such as charge and fluidity- for example, saturated, long-
chained phospholipids result in a less permeable, more rigid structure, while unsaturated 
lipids will result in a more permeable but less stable structure.76  The ability to tune their 
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properties in this manner makes it easy to produce liposomes for a wide range of different 
uses, and their potential applications in a range of areas, particularly medicine and 
pharmaceuticals, has been widely explored. 
They have found use in medicine as they provide excellent drug-carrying capabilities. 
As liposomes are biocompatible and non-toxic, being made of the same substances as cell 
membranes, and readily fuse with cell membranes,76 they are an excellent choice for 
introducing substances into the body. They are able to carry both hydrophobic and 
hydrophilic drugs in the lipid and water core sections of the liposome, respectively.  This 
ability to control the movement of drugs to their target site allows for lowered exposure of 
sensitive tissues to drug and the reduction of toxicity, as well as improving the efficacy of the 
drug as it can be released nearer its target site.  The fact that the drug is carried within the 
liposome itself rather than being exposed directly to the body during administration can also 
help to improve the drug’s stability within the body as it is protected from pH changes, 
enzyme activity, and other biological processes that may damage it.78 
Liposomes can be introduced into the body by a variety of routes including injection79 
and inhalation78 as well as topically,80 allowing them to be used for a range of purposes and 
to deliver drugs through the most appropriate route.  Overall, liposomes are a versatile tool 
in medicine, and additionally they have several non-medical applications too including in the 
formulation of cosmetics and in the food industry, where their ability to sequester harmful 
compounds and release molecules in a controlled fashion can be applied in processes such as 
fermentation and controlled release of pesiticides.5 
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1.10 Model Membranes 
Bacterial membranes are complex, dynamic structures containing various embedded and 
associated proteins and lipids.  Which proteins are present and in which quantities can vary 
greatly between species and, due to the complex nature of the lipid membrane, accurately 
re-creating a bacterial lipid membrane for use in studies would prove to be highly difficult.  
Through the selection of the appropriate lipids in the desired quantities, systems mimicking 
the lipid composition of various biological systems can be constructed fairly easily with a high 
degree of precision and used to gain insight into the behaviour of these membranes, as they 
retain the basic lipid bilayer structure while allowing for the investigation of the precise 
effects of individual components.81 
Commonly used model membranes include supported lipid bilayers (SLBs) which are 
readily formed through the fusion of vesicles or deposition of a Langmuir monolayer onto 
substrates such as mica or silica, and are able to maintain excellent mechanical stability.82  
Lipid monolayers formed on water/buffer surfaces in Langmuir-Blodgett troughs are also 
commonly used as information on the mean molecular area, compression modulus and 
interactions occurring between components at the air-water interface can be analysed using 
pressure-area isotherms.83  Liposomes can also be used as model lipid membranes,43 as 
diffusion in and out of the core can be used to study diffusion across cell membranes, and can 
be used to study the effect of various membrane components on stability through 
examination of their zeta potential.84 
However, studying mesophases and the transitions between them can also provide 
valuable information into the behaviour of biological lipid membranes and be used as models 
to glean insight into the effects of individual components.  While the Lα phase is the state in 
which lipid membranes usually exist within cells, other mesophases and the transitions 
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between them have also been suggested to play a biological role.  For example, it has been 
suggested that saddle deformations as seen in bicontinuous cubic phases may be induced by 
some membrane proteins,85 while the non-bilayer HII and QII phases have been proposed to 
resemble intermediates in the modified stalk theory of lipid membrane fusion.86   
Studying mesophases with composition resembling the compositions of lipid 
membranes can be used to construct phase diagrams to observe the effect of various 
environmental changes such as pressure and temperature as well as the presence of specific 
membrane components on the behaviour of various lipid systems and how these factors may 
affect cell processes such as fusion. 
 
1.11 Project Justification 
Cardiolipin, PE and PG are all lipids commonly found in bacterial membranes and have been 
used previously as bacterial membrane mimics,87, 88 including DOPE, DOPG and CL 
specifically.54  These lipids can be used to mimic a bacterial membrane, and so were chosen 
for this project for that purpose.  These lipids are all available in an easy to use, high-purity 
form from Avanti Polar Lipids and are readily soluble in water.  The lipids were used in 
proportions analogous to those found in bacterial lipid membranes53, 89- 70:20:10 
DOPE:DOPG:CL. 
The effect of cardiolipin’s presence on bacterial membrane mimics specifically has not 
been widely studied, despite the knowledge that it plays a role in shaping the properties of 
lipid membranes.  Therefore, there exists an opportunity to gain greater insight into the effect 
of this unique molecule on bacterial membranes and thus gain a deeper understanding of the 
properties of bacterial membranes in general.  Mesophases in excess water were chosen as 
model membranes to investigate the effect of cardiolipin’s presence firstly because of the 
38 
 
proposed biological relevance of mesophases in important cellular processes and secondly 
because they can be investigated using high-pressure SAXS, which provides quantitative 
structural information about the system and can be used to construct a pressure-temperature 
phase diagram to obtain a clear overview of the phase transitions the system undergoes and 
the effect of cardiolipin on these transitions.  Three different pH values were also chosen for 
investigation- 12.1, 5.1 and 1.3.  The pKa values of the two head groups of cardiolipin are 
approximately 2.8 and 7.5-9.5, and so the values chosen are above both head group pKa 
values, above one, or below both, with a view to investigate the effect of differing protonation 
states of the head groups on the behaviour of cardiolipin within the membrane. Polarised 
light microscopy can also be used to identify lipid mesophases,90 and so was used to obtain 
images of all systems identified via HP-SAXS to aid in characterisation and help confirm the 
assigned mesophases from the HP-SAXS measurements.  Liposomes were also used as a 
model membrane system to investigate the effect of cardiolipin on the stability of liposomes 
over time at different pH values, as the role cardiolipin plays in the stability of liposomes and 
in particular the role it plays in membrane stability under differing pH is another interesting 
area for investigation that has not been widely investigated, particularly as cardiolipin can act 
as a proton trap within membranes and may be able to act as a buffer.68 
Given that cardiolipin is a unique, significant and pH-responsive component of the 
membrane, it is a clear target for investigation. Investigating its role in shaping both the phase 
behaviour, stability and response to pH of bacterial membrane mimics can help to shed light 
on the behaviour of bacterial membranes under different conditions, an area that is 
important to investigate in light of the ongoing need to better understand the bacterial 
membrane and how it can be disrupted. 
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Chapter 2. Methods & Experimental 
 
2.1 Introduction to X-Rays 
X-Rays lie in the section of the electromagnetic spectrum with wavelengths between 0.01 and 
10 nm, or corresponding frequencies 3x1016 - 3x1019 Hz. They were first discovered in 1895 
by Wilhelm Röntgen, who named them ‘X-rays’ to signify the fact that at the time they were 
an unknown type of radiation, having been previously detected as an unidentified discharge 
occurring during experiments with cathode rays.  Only later were they identified as 
electromagnetic radiation with a shorter wavelength than visible light.91  Following their 
discovery as part of the electromagnetic spectrum, their potential for use in medicine was 
quickly developed in the years before the first world war, as it was found that they were able 
to penetrate different tissues within the body to differing extents, allowing for images of 
bones and foreign objects within the body to be obtained.  This property was used in the 
location of foreign objects and diagnosis of fractures, breaks, disease and tumours, and X-rays 
remain an essential tool in medicine in modern day.  In the 1920s, it was found that X-rays 
could be used not just in the imaging but in the treatment of cancers, and their ubiquity in 
the medical field including screening for tuberculosis in the 1930s and 1940s only increased.91  
However, X-rays have found use beyond the field of medicine- 17 years after the discovery of 
X-rays, and it was discovered by Max von Laue that, when X-rays are shone through a crystal, 
a diffraction pattern is produced, composed of specific wavelengths with intense peaks of 
radiation.92  Following on from this discovery, in 1913 Sir William Henry Bragg and Sir William 
Lawrence Bragg determined that this phenomenon was a result of constructive interference 
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arising from reflections by parallel planes within the crystal, and from this they proposed 
Bragg’s Law (equation 5):93 
 2𝑑 sin 𝜃 = 𝑛𝜆 
 
Equation 5 
where n is a positive integer, λ is the wavelength of the incident wave, and d is the interplanar 
distance, which can be used to find the interplanar spacing present in a crystal for 
identification or structure determination.  Unlike visible light, the wavelength of X-rays is 
comparable to the distances between atoms within molecules, and so X-rays were found to 
be able to provide unprecedented insight into the structure of molecules. 
   Following this realization in the first half of the 20th century, techniques such as X-
ray crystallography, famously used to confirm the structures of penicillin and vitamin B12 by 
Dorothy Hodgkin,  X-ray powder diffraction, and small-angle X-ray scattering were developed 
and are used in the present day to great effect in the determination of the structures of 
molecules, proteins, and other biological and chemical structures. 
 
2.2 Introduction to SAXS 
Small-angle X-ray scattering is an analytical technique used to determine structural 
information of a sample on nanoscales.  It does this by analysing the elastic scattering of hard 
X-rays when passed through a sample at small angles. Here, elastic scattering is scattering in 
which no energy is transferred and hard X-rays are more penetrating, using higher-energy X 
rays with a wavelength below approximately 0.2 nm.  SAXS is able to determine information 
about structures ranging in size from approximately 1-100 nm, with smaller scattering angles 
being required to probe larger structures. 
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  The principle of SAXS is that a monochromatic (composed of only one wavelength) 
beam of X-rays is shone through the sample (Fig. 7), where it interacts with the electron cloud 
present in the sample, undergoes a directional change and interferes constructively and 
destructively, resulting in a fringe pattern that is characteristic of the phase present (Fig. 8).   
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Phases can then be assigned by comparing the scattering vector Q for each peak.  Q is 
calculated from the difference between the scattered and the incident wave vectors 
according to equation 6 (illustrated in Fig. 7):94 
 
 
𝑄 = 𝑘𝑖 − 𝑘𝑓 =
4𝜋𝑛 sin 𝜃
𝜆
 
 
Equation 6 
and can then in turn be used to determine the d-spacing present in the sample using equation 
7. 
 
𝑑 =
2𝜋
𝑄
 
 
Equation 7 
Different mesophases give rise to different peaks according their lattice planes, which can be 
used to identify them.  In the case of lamellar phases, which comprise lipid bilayers separated 
by water channels, the unit cell consists of a bilayer and the layer of water adjacent to it.  All 
Fig. 9.  Illustration of the HII phase with arrows indicating the positions of the (100), (110) 
and (010) planes.  The bold lines indicate the unit cell, and the blue arrow indicates the z-
axis.  Adapted from reference 42. 
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of the planes present are parallel, giving rise to reflections from the (100), (200), (300)… 
planes, and resulting in evenly spaced peaks with Q ratios of 1:2:3… 
Hexagonal phases, however, have a different unit cell (Fig. 9).95  This results in a 
different set of peaks arising from SAXS, corresponding to reflections from the (100), (110) 
and (010) planes.  As the (100) and (010) planes are parallel to the x and y axes respectively, 
they are equivalent and so only give rise to a single peak.  The characteristic peak ratios of 
some common lipid mesophases are summarized in table 2.75 
As well as being able to characterise mesophases, SAXS peak shapes can be analyzed 
to determine the coherence length of a sample, that is, the average size of the crystalline 
domains within the mesophase, through use of the Scherrer equation (equation 8): 
 
 
𝐿 =
2𝜋𝑘
∆𝑄
 
Equation 8 
 
where 𝑘 is the shape factor of order unity, and ∆𝑄 is FWHM.96 
Mesophase Characteristic peak ratios 
Planar bilayer 1, 2, 3… 
Inverse hexagonal phase 1, √3, 2… 
Bicontinuous cubic Pn3m √2, √3, 2… 
Bicontinuous cubic la3d √6, √8, √14… 
Micellar cubic Fd3m √3, √8, √11… 
Table 2. Characteristic peak ratios produced by various lipid mesophases from SAXS 
measurements. 
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The radius of gyration 𝑅𝑔, a measure of the size of the particles present in a sample, can be 
determined from SAXS using a Guinier plot where scattering is fit to equation 9: 
 
 
𝐼(𝑄) ≅ 𝐼(0)exp (−𝑄2
𝑅𝑔
2
3
) 
Equation 9 
 
where 𝐼(𝑄) is the scattering intensity, 𝐼(0) is the forward scattering intensity, and 𝑄 is the 
scattering vector.  However, this approximation is only valid when 𝑞𝑅𝑔<1.1 or 1.3 for globular 
particles.97  
 
2.3 Synchrotrons and X-ray generation 
Synchrotrons are a type of particle accelerator used to generate intense light for various 
scientific purposes.  They have numerous advantages over traditional methods of generating 
X-rays as they provide very intense beams, the X-ray wavelength can be selected, and the 
beam is naturally collimated.  Synchrotron radiation was first observed by accident in 1947 at 
the General Electric 70 MeV synchrotron, and following this in the late 1940s theory was 
developed to allow for accurate predictions about the properties of synchrotron radiation; 
further experiments were conducted by Pollack et al. on this synchrotron.  Further 
experiments with synchrotron radiation were then conducted throughout the 1950s in Russia, 
the USA and Germany, the theoretical predictions verified and the first synchrotron storage 
ring specifically for the purpose of generating synchrotron radiation was created at the 
university of Wisconsin in 1968.98 
Charged particles generate electromagnetic radiation when they pass through an 
electromagnetic field.  In a synchrotron, electrons in a storage ring are accelerated to close to 
45 
 
the speed of light and forced to change direction by magnets, with a narrow cone of X-rays 
being emitted perpendicular to the direction of the electrons’ acceleration.99  At Diamond 
Light Source, a high-voltage cathode is heated under vacuum to cause the thermionic 
emission of electrons, which are then accelerated by anodes to form a stream of electrons.  A 
linear accelerator is used to accelerate the electrons to 100 MeV, and then up to 3 GeV in a 
booster synchrotron.  The current in the storage ring is then kept constant through regular 
top-up injections of electrons.  The storage ring itself is made up of straight sections followed 
by corners that the electrons are forced to bend around by magnets, with the radiation 
emitted by the electrons at these corners passing first into an optics hutch where the required 
wavelengths of radiation are selected and focused, and then into an experimental hutch 
where the beam can interact with the sample and measurements be taken.  Following the 
experimental hutch is the control cabin where the equipment in the experimental hutch can 
be controlled remotely and data and be collected and processed.100 
 
2.4 The Effect of Pressure on Lipids and the use of HP-SAXS 
SAXS is an enormously useful technique for studying nanoscale structures, allowing for the 
study of the effects of changes on the physicochemical properties of systems, including lipids.  
It is useful for the  identification of liquid crystalline phases accurately and efficiently,96 and, 
when coupled with the use of high-pressure, provides a wealth of information about the 
phase behaviour of lipid systems. 
When pressure is applied to lipid systems, it particularly impacts on the volume of the 
lipid tails and changes their lateral stress.96 This results in changes in curvature elastic energy, 
and pressure can thus be used to induce phase transitions.  Lipids can undergo transitions 
from lamellar to non-lamellar phases or change from a flat bilayer to a curved one due to an  
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imbalance in the effect by the pressure change between the headgroups and tails of the lipids 
(figure 10), with a higher degree of lateral pressure in the chain region causing curvature 
inwards towards the headgroups and promoting the inverse hexagonal phase, a high degree 
of lateral pressure between the headgroups causing curvature inwards towards the chain.101 
It has been observed that increasing pressure has the opposite effect to increasing 
temperature in lipid systems, as increasing pressure results in a higher degree of constraint 
on the hydrocarbon tails, restricting their movement102 and increasing the ordering in the 
region, i.e. increasing pressure promotes the processes that reduce the volume of the 
system.103  As the cross-section of the head group is not as affected by pressure as the tail 
groups, the magnitude of preferred negative curvature is decreased with increasing pressure 
in inverse hexagonal systems, resulting in an increase in diameter of the cylinders present 
(Fig. 11) although only up to a point as voids between cylinders cannot form.103 
The effect of pressure on a lipid system can be quantified with the Clapeyron equation 
(equation 10): 
 
Fig 10. Illustration of the forces between head groups and tail groups of lipids.  Fh is the force 
present between the headgroups, which may be either repulsive due to steric or electrostatic 
effects, but may also be attractive due to charge or hydrogen bonding.  Fc is the repulsive 
force present between chains, due to cis-trans rotations and the resulting steric pressure. γ 
is the interfacial tension due to contact between the tails and the surrounding water, and 
works to minimise the interfacial area (adapted from reference 9). 
47 
 
 𝑑𝑇𝑡
𝑑𝑝
=
∆𝑉𝑚
∆𝑆𝑚
=
𝑇𝑡∆𝑉𝑚
∆𝐻𝑚
 
Equation 
10 
 
where 𝑇𝑡 is the phase transition temperature, ∆𝑆𝑚, ∆𝐻𝑚 and ∆𝑉𝑚 are the molar transition 
entropy, enthalpy and volume changes, respectively, and this linear relationship between 
pressure and  temperature hold for pressure up to approximately 200 MPa.103 
Using pressure rather than temperature to induce phase changes offers a number of 
advantages: high pressure does not tend to disrupt intramolecular bonding up to 
approximately 2 GPa, allowing for substances to be studied as they appear in nature; in 
addition, pressure can be applied and released on a micro-to-millisecond time frame, which 
allows for the kinetic effects to be observed in real-time and also for the effects of both 
increases and decreases in pressure to be observed. In contrast, temperature propagation 
and equilibrium typically is not established as fast and the time taken to heat and cool a 
sample is typically not equal.103 
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2.5 Introduction to Dynamic Light Scattering 
Dynamic light scattering (DLS) is a non-destructive, non-invasive analytical technique that can 
be used to determine structural information about particulate dispersions.  It is well-
established for collecting information such as size and polydispersity of the particles present 
and can be coupled with other techniques such as zeta potential as discussed later. As it is 
noninvasive the collection of data through DLS does not influence the behaviour of the 
sample. DLS is typically used to determine the Z-average size of particles in solution and their 
polydispersity index (PDI), where a value approaching zero represents a more monodispersed 
dispersion, meaning all particles are of a similar size; whereas a value approaching unit (1) 
reflects a more polydisperse dispersion, indicating the presence of particles of differing sizes.  
DLS also offers advantages of simple sample preparation and relatively fast measurements. 
To carry out DLS measurements, a monochromatic light source, typically a laser, is 
passed through a polariser and then into a sample, where, given that the particles are 
sufficiently small, it scatters in all directions in a phenomenon known as Rayleigh scattering. 
The scatter then passes through a second polariser and is collected by a photomultiplier which 
converts incident photons into an electrical signal for data processing.  This Rayleigh 
scattering results in what is known as a speckle pattern resulting from constructive and 
destructive interference of scattered light. As particles in solution are not static but rather 
subject to the Brownian motion resulting from the collision between particles and the 
molecules of the solution, this pattern changes over time. This dynamic information about 
the particles is derived from an autocorrelation of the intensity trace,104 and so for short time-
frames the correlation is high but decays exponentially for a monodisperse sample as the 
particles move further from their initial position. 
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As the movement of the particles is a result of collisions with solvent molecules, 
several factors influence the movement of the particles including temperature, size, and 
solvent viscosity.  The diameter of particles in solution can be derived from DLS through the 
Stokes-Einstein relation (equation 11):105 
 
𝐷 =
𝑘𝐵𝑇
6𝜋𝜂𝑅
 
Equation 
11 
where 𝑅 is the hydrodynamic diameter or particle size, 𝐷 is the translational diffusion 
coefficient, 𝑘𝐵 is the Boltzmann constant, 𝑇 is the temperature, and 𝜂 is the viscosity of the 
solution.  𝐷 is determined by first plotting the autocorrelation function against the delay time 
which yields the decay rate 𝛤 (equation 12):106 
 
 𝛤 = 𝐷𝑞2 Equation 
12 
where the wave vector 𝑞 is determined via equation 13:107 
 
 
𝑞 =
4𝜋𝑛
𝜆
sin(
𝜃
2
) 
Equation 
13 
In which 𝜆 is the incident laser wavelength, 𝑛 is the refractive index of the of the sample and 
𝜃 is the angle at which the detector is positioned relative to the sample cell.108 
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2.6 Zeta Potential 
The zeta potential is a measure of the electrokinetic potential at a solid-liquid interface, 
typically measured in mV.  When surfaces are exposed to a fluid, a structure known as an 
electrical double layer arises.  The first layer adjacent to the surface, the Stern layer, is 
composed of adsorbed ions.  The second layer or diffuse layer is composed of ions that are 
more loosely associated with the surface and are attracted to the first layer via the coulomb 
force.  The slipping plane is the name given to the boundary between the diffuse later and 
the bulk medium, with the zeta potential giving the potential difference between the area 
bounded by the slipping plane and the bulk medium (Fig. 12).109, 110 
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The zeta potential (ζ) is a key indicator of colloidal stability.  The presence of a large ζ 
indicates a large degree of repulsion between adjacent particles in solution, and therefore 
indicates a lower chance of particles aggregating and flocculating.  Likewise, a small ζ indicates 
that attractive forces may overcome the repulsive forces present and that aggregation is more 
likely.  Zeta potential is therefore a very useful measure of colloidal stability, with a larger ζ 
indicative of a more stable colloid and vice versa. 
It is not possible to directly measure zeta potential and so it can be measured 
indirectly through observing the electrophoretic mobility of particles, that is, how mobile 
particles are when subject to an electric field.  An electric field is applied to the sample and 
the doppler shift in a laser beam is used to measure the velocity (laser doppler velocimetry, 
LDV)111 of the particles by measuring small shifts in the frequency of the scattered light, which 
is used to calculate the electrophoretic mobility 𝑈𝐸.  The 𝑈𝐸 is then used to calculate the zeta 
potential 𝜁 using the Henry equation (equation 14): 
 
 
𝑈𝐸 =
2𝜀𝜁𝐹(𝜅𝑎)
3𝜂
 
Equation 14 
 
Where 𝜀 is the dielectric constant, 𝜂 is the viscosity of the medium, 𝐹(𝜅𝑎) is the Henry 
function, and 𝜅𝑎 is the measure of the ratio of the particle radius to the Debye length.109 
Typically, particles with a zeta potential of +/- 10 mV are considered to be fairly 
neutral, while a zeta potential of more than +30 mV or less than -30 mV is considered to 
indicate the presence of highly charged particles.111 
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2.7 Introduction to Polarising Light Microscopy 
Polarised light microscopy (PLM) is an easy-to-perform microscopy technique that can be 
used to identify structurally anisotropic crystalline or crystalline-like regions in samples 
including biological samples and lipids,112 and has been in use through the 20th century and 
in modern day.  Crystalline materials affect the speed at which light passes through them, and 
while for isotropic materials the refractive index is the same in all directions, this is not true 
for crystals, which are termed anisotropic and have more than one refractive index.112  This 
results in a property known as birefringence, which cannot be detected by a typical light 
microscope but can be detected using a polarising light microscope. PLM can thus be used to 
quickly and easily identify crystalline regions and can complement other more quantitative 
techniques such as SAXS.113 
Polarising light microscopes work by having one polariser between the light source 
and the sample and a second to analyse the polarisation of the light after passing through the 
sample.  Typically, birefringent regions of a sample appear to be brightly lit and coloured while 
other areas appear dark, making identification of crystalline areas fast and simple. Objects 
with a greater difference between their two refractive indices appear brighter than objects 
for which this difference is smaller, and thicker objects will also appear brighter than thinner 
ones with the same difference between refractive indices.  Brightness is also greatest when 
the object is at 45° to the planes of polarization, and is at a minimum when the object is 
parallel to one of these planes, i.e. it is not visible.114 
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 2.8 General Methods 
Cardiolipin, DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine) and DOPG (1-2,dioleoyl-
sn-glycero-3-phospho-(1’-rac-glycerol)) were purchased in chloroform solution from Avanti 
Polar Lipids and stored at -30°C until use.  Glassware used to prepare lipid solutions was 
cleaned in 10% nitric acid  by submerging it in the acid bath for a minimum of one hour, 
transferred to water purified by a MilliQ advantage a10 purification system and then rinsed 
with MilliQ water before being dried in a Heraeus Vacutherm VT 6025 vacuum oven. 
  
2.8.1 Preparation of pH solutions 
pH solutions of 1.3, 5.1 and 12.1 were prepared using hydrochloric acid (Fischer Scientific, 
37%) or sodium hydroxide pellets (Sigma Aldrich, 99.99%) as appropriate, and measured using 
a Hanna Instruments HI-2550 pH/ORP & EC/TDS/NaCl benchtop pH meter. 
  
2.8.2 Preparation of samples for HP-SAXS 
HP-SAXS samples were prepared by measuring out appropriate volumes of lipid solution into 
glass vials, which were then dried overnight in a Heraeus Vacutherm VT 6065 vacuum oven 
at room-temperature. The dried lipids were re-dissolved in 300 μL chloroform with desired 
and then dried at room temperature overnight again.  Samples were then rehydrated with 
100 uL of the pH appropriate solution before being vortexed vigorously for approx. 10 s and 
then sonicated for 90 minutes at room temperature.  Samples were then left overnight 
(approx. 18 h) in an incubator shaker at 45 C, 600 rpm, before being vortexed for a further 10 
s each and then subjected to five freeze-thaw cycles between warm water (approx. 40 oC) and 
an acetone/dry-ice bath (approx. -78°C). 
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 2.8.3 HP-SAXS Measurements 
HP-SAXS measurements were carried out at beamline I22 at Diamond Light Source, 
Oxfordshire, UK.  The X-ray beam was positioned 5.76 m from the sample, sized 180 x 100 μm 
and had an energy of 18 keV. The detector used was a Pilatus P3-2M. A high-pressure cell as 
described by Brooks et al.115 was used to hold the samples, which were contained in 
polycarbonate capillary tubes of approximately 20 mm length, outer diameter 2.08 ± 0.01 
mm, and 0.10 ± 0.03 mm (Spectrum Plastics, Georgia, USA).  The tubes were sealed with 
Araldite Instant 90 s G Resin (Huntsman Advanced Materials, Everberg, Belgium), cured at 
60°C for approximately 30 min. 
Before measurements were taken, samples were cycled from 1-4000 bar to further 
homogenise the samples and check for leaks and damage to the sample.   Data was collected 
by increasing the pressure from 1 to 3000 bar in increments of 300 bar at a range of increasing 
temperatures, with an exposure time of 100 ms per image, before cooling the sample to the 
initial temperature and completing another pressure cycle to check for any hysteresis and 
radiation damage.  An additional image was also collected gain at 1 bar after each 
temperature for the same reasons.  2D scattering patterns were collected and converted into 
1D intensity vs Q plots and the beamline background subtracted using the software DAWN, 
and the phases were then determined by peak fitting with Voight or Gaussian functions in 
Igor Pro. 
 
2.8.4 Preparation of samples for Polarising Light Microscopy 
HP-SAXS samples were prepared by measuring out appropriate volumes of lipid solution into 
glass vials, which were then dried overnight in a Heraeus Vacutherm VT 6065 vacuum oven 
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at room temperature, re-dissolved in 300 uL of chloroform, combined to make samples of the 
required composition and then dried at room temperature overnight again.  Samples were 
then rehydrated with 100 uL of MilliQ water at a designated pH before being vortexed 
vigorously for approx. 10 s and then sonicated for 90 minutes at room temperature. Samples 
were vortexed for a further 10 s each and then subjected to five freeze-thaw cycles between 
warm water (approx. 40°C) and an acetone/dry-ice bath (approx. -78°C).  PLM images were 
then captured with an Olympus BX53-P microscope, with polarisers crossed at 90° and images 
captured with Stream software (multi-lipid systems) or a Nikon Eclipse E200 microscope, with 
polarisers crossed at 90° and images captured using PikeLINK Capture OEM software.  A 530 
nm first-order waveplate was used, providing enhanced contrast.  All images were processed 
with Fiji image processing software. 
 
2.8.5 Preparation of samples for Dynamic Light Scattering and Zeta potential 
measurements 
DLS samples were prepared by measuring out the appropriate volumes of lipid solutions into 
glass vials and then drying overnight in a vacuum oven at room temperature before being 
rehydrated with 1 mL of water at a designated pH.  Samples were then subjected to 5 freeze-
thaw cycles between warm water and an acetone/dry-ice bath, sonicated for 90 min and 
diluted to a concentration of 0.1 mg mL-1.  Samples were then extruded using a Lipex 10/1.5 
mL thermobarrel extruder at 60°C, 10 times through a 200 nm pore size polycarbonate filter 
and then 10 times through a 100 nm filter.  The resulting liposome dispersions were stored in 
a fridge between measurements. The solutions were divided into two equal portions, with 
56 
 
one portion being sonicated for 90 min at room temperature prior to each DLS measurement 
and the other not.   
 
 
Chapter 3. HP-SAXS study on the effect of cardiolipin, temperature, 
pressure and pH on the phase behaviour of a model bacterial 
membrane 
 
 
3.1 Abstract 
The effects of cardiolipin and pH on the phase behaviour of a model E. coli bacterial membrane 
lipid system, consisting of DOPE, DOPG and Cardiolipin in a 70:20:10 ratio, have been 
investigated.  A critical comparison is made with the control sample comprising DOPE/DOPG 
in a ratio of 78:22.  DOPE/DOPG/CL samples were prepared at pH 1.3, 5.1, and 12.1 and 
DOPE/DOPG at 5.1, to allow for the investigation of the effects of pH on the phase behaviour 
of the system.  Pressure-temperature (p-T) phase diagrams of the lipid systems were obtained 
using high-pressure small-angle X-ray scattering (HP-SAXS) at Diamond I22 with a pressure 
range of 1-3000 bar and a temperature range of either 20 - 60°C (for DOPE/DOPG/CL at pH 
1.3) or 20 - 45°C (for DOPE/DOPG and DOPE/DOPG/CL at pH 5.1).  Peak-fitting was carried out 
for assigning the mesophases and the analyses of the d-spacing and coherence length L of the 
samples.  For both DOPE/DOPG/CL and DOPE/DOPG at pH 5.1, the lamellar alpha (Lα) phase 
was observed under ambient conditions with a single transition to the lamellar beta (Lβ) phase 
at high pressure at 20 and 25°C.  At pH 12.1, the mesophase behaved in the same manner as 
at pH 5.1; However, at pH 1.3, the mesophase primarily existed in the inverse hexagonal (HII) 
phase with a transition to an unidentified phase at high pressure at 20 and 30°C.  The presence 
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of cardiolipin was found to have a small impact on the phase behaviour of the system at pH 
5.1, with the Lβ phase appearing at a lower pressure at 20°C in its presence.  The presence of 
cardiolipin resulted in a larger d-spacing and ∆𝑑/∆𝑝 gradient at all temperatures and 
pressures studied at pH 5.1, and a lower d-spacing and shallower ∆𝑑/∆𝑝 was observed at pH 
12.1 compared to pH 5.1.  A difference was also observed between the coherence lengths of 
the pH 5.1 samples, with the presence of cardiolipin resulting in a greater decrease in 
coherence length with increasing temperature. 
 
3.2 Results & Discussion 
As previously discussed, small-angle X-ray scattering (SAXS) is a useful tool for characterising 
lipid mesophases and obtaining a wealth of information including d-spacing and coherence 
length.  For this chapter, the data obtained at beam line I22 were first plotted and the peaks 
fitted using Igor Pro (Fig. 13 A.) to establish pressure-temperature (p-T) phase diagrams for 
Fig. 13.  Illustration of the peak-fitting process in Igor Pro using data collected in this 
experiment.  On the left (A), part of the process of peak-fitting is shown (taken from CON2 
at T = 25°C and p = 2700 bar), with two peaks identified and assigned to the Lβ and Lα phase 
respectively.  On the right (B), full SAXS patterns obtained for selected pressures from 
CON2 at T = 25°C are shown to illustrate the phase change that occurred. 
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the samples from p = 1-3000 bar, with a temperature range 20 - 60°C  (varying with samples). 
This range was chosen to encompass biologically relevant temperatures (Table 3 and Fig. 13.).  
The p-T diagram for CON2 was first established as a control, followed by samples CL1, CL2 and 
CL3 to investigate the effects of the presence of cardiolipin and changes in pH on the phase  
behaviour of the system. 
 
3.2.1 Phase behaviour of lipid systems 
 Different phases were assigned by examining the Q values of the peaks to obtain 
characteristic peak ratios.  In Fig. 13 B., at p = 1 bar the peaks are present in a 1:2:3… ratio, 
indicating the presence of a lamellar phase, identified as the Lα phase.  At p = 2700 bar, a 
phase transition occurred, evidenced by the emergence of a second set of peaks (shown in 
green) alongside the peaks arising from the Lα phase (shown in blue).  Peak fitting reveals the 
presence of a mixed phase, with overlapping peaks belonging to the two different phases 
obtained.  At p = 3000 bar, the peaks belonging to the Lα phases are no longer present, 
signalling that at this pressure the phase transition to the Lβ phase was complete. 
 Samples CON2 and CL2 were studied in the temperature range  20-45°C, and 
the Lα phase were present exclusively at the majority of the p-T phase diagram (Fig. 2 A & C)  
Sample Name Lipid Composition Lipid Ratio pH 
CON2 DOPE/DOPG 78:22 5.1 
CL1 DOPE/DOPG/CL 70:20:10 1.3 
CL2 DOPE/DOPG/CL 70:20:10 5.1 
CL3 DOPE/DOPG/CL 70:20:10 12.1 
Table 3. Samples investigated via HP-SAXS in this work 
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Fig. 14. (A & B) Pressure-temperature phase diagrams for lipid mesophase systems at 
pH 5.1.  Blue circles indicate the presence of the Lα phase, yellow circles indicate the 
presence of a mixed Lα/Lβ phase, and green circles indicate the presence of the Lβ phase.  
SAXS patterns for CON2 (B) and CL2 (D) at pH 5.1 and T = 20°C.  Blue corresponds to the 
La phase, yellow to a mixed Lα/Lβ phase and green to the Lb phase.  The pale blue trace 
corresponds to the repeated measurement for p = 1 after the pressure cycle was 
completed.  E: structures of lipids used in samples and diagrams of lipid mixtures used 
in samples.  Blue lipid headgroups represent DOPE, brown head groups represent DOPG 
and yellow head groups represent cardiolipin, corresponding to the chemical structures 
of the lipids shown on the right. 
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with only the Lα phase observed at temperatures of 30°C and above for both systems.  One 
phase transition was observed in each system from the Lα phase to the Lβ phase at both 20  
and 25°C; however, the pressure at which this transition was complete was slightly lower in  
the presence of cardiolipin;  for CON2 at T = 20°C, a mixed phase was present at p = 2400 bar 
between p = 2100 and 2400 bar.  
The pressure-temperature phase diagram for pure DOPE has previously been 
established by Bulpett et al.,96 who found that at ambient pressure and temperature, DOPE 
forms an inverted hexagonal phase, only transitioning to the Lα phase above approximately p 
= 600 bar.  The Lα -> Lβ transition was still observed at higher pressures, taking place at 
ambient temperature at p > 2000 bar.  Comparing the findings of Bulpett et al. to CL2, which 
contains DOPE as the major component, it is clear that the addition of DOPG has a significant 
impact on the phase behaviour of the DOPE, preventing the formation of the inverted 
hexagonal phase under ambient conditions and increasing the pressure needed to achieve 
the Lβ phase from approx. 2000 bar to 2700 bar.  This is consistent with the findings of Morein 
at al. however, who found that under ambient conditions and at pH 7.4, DOPE/DOPG in a 7:3 
ratio forms the Lα phase.116  Although DOPE and DOPG have identical tail groups, their head 
group areas are different.  This may explain the difference seen between the established 
phase behaviour of DOPE and CON2, i.e. changes in the lipid packing due to addition of DOPG 
wherein the lipids are not able to pack as closely due to the differeing headgroup areas and 
so a greater pressure is required to form the Lβ phase.  
The finding that the addition of cardiolipin slightly lowered the pressure at which the 
Lα -> Lβ  phase transition is complete from 2700 to 2400 bar (Fig. 14 A & C) is likely due to a 
change in the packing of the lipid chains, possibly due to the increased lateral pressure CL 
introduces into bilayers.63  For both CON2 and CL2, increasing temperature increased the 
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pressure required to produce the gel phase, in line with expectations, as pressure increases 
the constraint on the hydrocarbon tails and restricts their movement thereby promoting the 
gel phase, while increasing temperature increases the lateral pressure between tail groups, 
working to produce the opposite effect. 
 Aside from the Lα -> Lβ transition happening at 300 bar lower pressure at T =  20°C for 
CON2 (Fig. 14 A & C), the p-T phase diagrams collected for both systems are highly similar 
suggesting that cardiolipin only had a subtle effect on the phase behaviour of the system at 
pH 5.1.  
As mentioned previously, at pH 5.1, cardiolipin carries a single negative charge, and 
so repulsion between its two head groups is present but not at a minimum as when no 
negative charge is present.  For pH 12.1, when cardiolipin carries two negative charges, data 
was only collected for T = 20°C (Fig. 15).  It was found that for sample CL3, the system was in 
the Lα phase from p = 1-2100 bar, and then in the Lβ phase from p = 2400 to 3000 bar, behaving 
in the same way as CL2 (Fig. 14 A & C). 
3000 bar
2700 bar
2400 bar
2100 bar
1800 bar
1500 bar
1200 bar
900 bar
600 bar
300 bar
1 bar
1 bar
Fig. 15. SAXS patterns for CL3 at T = 20°C.  Blue corresponds to the Lα phase, and green to the 
Lβ phase.  The pale blue trace is the repeated measurement for p = 1 bar after the pressure 
cycle was completed. 
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However, the system behaved very differently at pH 1.3 (Fig. 16. A), when cardiolipin 
carries no negative charge and repulsion between its two head groups is at a minimum.  At 
ambient pressure, the system was in the inverse hexagonal phase (Fig. 16. B) at all 
temperatures studied (T = 20-60°C).  This increased propensity towards the inverse hexagonal 
phase at acidic pH may be due to the decreased repulsion between the incorporated 
cardiolipin head groups, allowing for an increase in the packing parameter of the individual 
molecules and increasing their preference to form inverted phases with negative curvature 
relative to when only a single or no negative charge is present.  However, a control p-T 
diagram of DOPE/DOPG only at pH 1.3 would be required to establish this.  Increasing the 
pressure of this system beyond approximately p = 1800 bar at T = 20 and 30°C resulted in a 
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mixed system composed partially of the inverse hexagonal phase, and partially another phase 
with peaks positioned at approximately 0.05, 0.07 and 0.11 Å-1, with only this phase being 
present at T = 20°C at pressures at and above approximately p = 2700 bar.  These peak ratios 
do not appear to correspond to the established peak ratios for the lamellar, inverse hexagonal 
or any cubic phases and so could not be identified.  
As discussed above, the differences seen between the mesophase at pH 1.3 and at pH 
5.1 and 12.1 (Figs. 14, 15 & 16) are in line with expectations.  At higher pH where cardiolipin 
has one or more negative charges on its two headgroups, the repulsion between the two 
headgroups is increased, decreasing the packing parameter as the flexibility of the molecule 
is reduced.  At lower pH, with no charge and so minimal repulsion between the headgroups, 
the increased packing parameter causes a greater tendency towards negative curvature. 
As well as cardiolipin, the potential contributions of the other two lipids in the system- 
DOPE and DOPG- cannot be overlooked.  DOPE is a neutral lipid that, due to its two cis double-
bonds which introduce kinks into the chains, has a low chain-melting transition temperature 
relative to many other common lipids, of -16°C. 117 As observed by Bulpett et al96 pure DOPE 
exists in the HII phase at atmospheric temperature and pressure, transitioning to the Lα and 
then the Lβ phase with increasing pressure (p = 600 and p = 2100 bar, respectively, at T = 
20°C).  As the temperature increases, higher pressures are needed to induce the transition to 
the Lβ gel phase.  As DOPE made up the bulk of the model mesophases used in this work, it 
was predicted that the phase behaviour of these mesophases may approximately follow the 
observed behaviour of pure DOPE.  DOPG also has a low chain-melting transition temperature 
of -18°C,117 but in contrast to DOPE is anionic and tends to exist in lamellar phases under 
ambient conditions when not in the presence of divalent cations.118  The key difference 
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observed with the addition of DOPG alone to DOPE was the disappearance of the inverted   
hexagonal phase observed under ambient conditions in pure DOPE,96 with only lamellar 
phases appearing, demonstrating the stabilising effect DOPG has on the Lα phase.  
Another feature of note in the SAXS measurements obtained is the presence of 
scattering curves at higher Q values on the traces at pH 5.1 and 12.1 at all pressures and 
temperatures studied (Figs. 14 & 15), and at p = 2400 and above in the pH 1.3 measurements 
(Fig. 17.), indicating the presence of not just mesophases but particles in the samples 
studied.119  It is likely that these particles are vesicles due to the methods of preparation used, 
formed during the sonication step.  The shape and size of the particles could be obtained 
through fitting, however attempts using SASview software were unsuccessful due to the 
presence of peaks amongst these curves.  Also noticeable is that no vesicles are present at 
Fig. 17. SAXS data for CL1 at T = 20°C.  Red traces indicate p = 1-1800 bar (bottom to top) 
and the presence of the HII phase, orange traces indicate the presence of a mixed phase at 
p = 2100 and 2400 bar and blue traces indicate the presence of a new phase at p = 2700 
and 3000 bar. 
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the same time as the hexagonal phase at pH 1.3, but start to appear at lower temperatures 
and high pressures when the system undergoes a phase transition. 
Guinier and Porod fitting could have aided in characterising these particles, however 
due the lack of validity of the Guinier approximation when applied to this data (𝑞𝑅𝑔 was not 
within the accepted limit of <1.3)97 and the fact that fitting was difficult due to the presence 
of multiple peaks in addition to the scattering curves, this analysis was not carried out. 
 
 
Fig. 18. Effect of pressure, temperature and lipid composition on the d-spacing of the lamellar 
mesophases in samples CON2, CL2 and CL3. 
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3.2.2 d-spacing of lipid systems 
However, information on the changes in d-spacing caused by temperature and pressure could 
be obtained from this data (Fig. 18).  It was found that the d-spacing of CL2 was larger relative 
to CON2, indicating that the cardiolipin played a role in increasing the distance between the 
lipid bilayers.  As seen in Fig. 19. A & C, at all temperatures, the gradient ∆𝑑/∆𝑝 was also 
greater for CL2 than for CON2, with increasing pressure having a greater effect on the d-
Fig. 19. Linear fits carried out for CON2 (A) and CL2 (C) to obtain ∆𝑑/∆𝑝 and  ∆𝑑/∆𝑝 
against temperature for CON2 (B) and CL2 (D). 
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spacing of CL2.  In Fig 19. B & D, ∆𝑑/∆𝑝 against temperature is shown for CON2 and CL2 
respectively, with ∆𝑑/∆𝑝 for CON2 increasing between T = 25 and 35°C before decreasing 
slightly at T = 45°C.  Conversely for CL2, ∆𝑑/∆𝑝 decreased with temperature aside from T = 
35°C where an increase in ∆𝑑/∆𝑝 occurred.  The ∆𝑑/∆𝑝 values found are in agreement with 
literature, with an increase in pressure causing a decrease in the fluidity and disorder of the 
lipid chains, and an increase in their extension.120  This was found to be the case for CON2, 
CL2, and CL3, although ∆𝑑/∆𝑝 for CL3 (Fig. 20) at the temperature studied (T = 20°C) was 
lower than ∆𝑑/∆𝑝 at 25°C for either CON2 or CL2 at 2.46 x 10-4 Å bar-1 vs 5.07 x 10-4 Å bar-1 
and 1.32 x 10-3 Å bar-1 respectively (Fig. 19. A & C), suggesting that pH may have influenced  
the responsiveness of the system to increasing pressure.   
 
Fig. 20. Linear fit for CL3 at 20°C to obtain ∆𝑑/∆𝑝 
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The transition from the Lα to the Lβ phase was accompanied by a significant increase 
in d-spacing, as in gel phases the lipid chains are further extended as the lipids change 
conformation to accommodate the restriction imposed on their volume by the pressure.94  
Although it was also expected that increasing temperature would result in smaller d-spacing 
due to the increased fluidity of the chains, this was observed for CL2 but not for CON2.  While 
data for only one temperature was obtained for CL3, it is seen that the d-spacing at this pH is 
significantly lower than it is at pH 5.1, however, without a control sample it is unclear if this 
is due to changes in the charge on cardiolipin’s head group or other factors related to DOPE 
and DOPG.  
The changes in lattice parameter a for sample CL1 are shown in Fig. 21.  As previously 
mentioned,72 in hexagonal systems an increase in pressure causes an increase in cylinder 
diameter, and this was observed here.  At all temperatures studied, the lattice parameter a 
Fig. 21. The effect of pressure on the lattice parameter a for sample CL1 with linear fits 
used to obtain ∆𝑑/∆𝑝 
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increased with pressure, and increasing temperature resulted in a decrease in a, likely due to 
the increased fluidity of the tail groups.  ∆𝑑/∆𝑝 decreased with temperature and was greater 
than ∆𝑑/∆𝑝 for CON2, CL2 and CL3, these being in the lamellar phase while CL1 was in the HII 
phase, indicating that this system was more sensitive to the effects of pressure. 
 
3.2.3 Coherence length of lipid systems 
The changes in coherence length L were also obtained from the samples studied.  For both 
CON2 and CL2, the coherence length of the samples roughly increases as temperature 
decreases (Fig. 22), likely due to higher temperatures resulting in a higher degree of chain 
disorder.  A notable exception to this is CON2 at T = 45°C (Fig. 22. A), it is unclear why the 
trend is so different at this temperature, and repeat measurements are needed.  For both 
samples, the coherence length for the sample when in the Lβ phase is significantly lower than 
when they are in the Lα phase.  For CL2 (Fig. 22. B), the coherence lengths decrease at all 
temperatures at p = 3000 bar even when the Lβ phase is not observed.  A noticeable difference 
between CON2 and CL2 is that increasing the temperature of the system with cardiolipin 
present appeared to cause a greater decrease in coherence length than without the presence 
of cardiolipin, and this may be due to cardiolipin disrupting the packing of the membrane, 
with the large tail area reducing the efficiency of the packing and decreasing the long-range 
order of the mesophase.  
 Although there is no control sample data available to assess the impact of cardiolipin 
on the coherence length of the sample at pH 12.1 (Fig. 23), it is noticeable that at this pH the 
coherence length is lower on average than the same system at pH 5.1, indicating that pH did 
have some effect on the ordering of the lipids, although a comparison with a DOPE/DOPG  
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Fig. 22. The effect of pressure and temperature on the coherence length L of CON2 (A) and 
CL2 (B) 
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system at pH 12.1 would be needed to establish if this effect is due to the differing charge 
states of cardiolipin or another factor. 
For CL1 (Fig. 24), the coherence length was significantly lower than for the samples 
that formed lamellar phases, and also increased gradually with pressure rather than 
decreasing, with pressure reducing the disorder of the inverse hexagonal phase.  After 
transition to the unknown phase (above p = 1800 bar at T = 20°C and above p = 2400 bar at T 
= 30°C), the disorder decreases significantly compared to when the inverse hexagonal phase 
is present.  
 
 
 
Fig. 23. Effect of pressure on the coherence length L of CL3 at 20°C 
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3.3 Conclusions 
In summary, it was found that at pH 5.1, the presence of cardiolipin had subtle but 
noticeable effects on the behaviour of the system, slightly lowering the pressure required to 
induce the Lα -> Lβ phase transition at T = 20°C, increasing the d-spacing of the lamellar phases 
formed and increasing the impact of temperature changes on the coherence length of the 
system.  It was also found that pH had a large impact on the behaviour of the DOPE/DOPG/CL 
system, with an inverse hexagonal phase forming at pH 1.3 and lamellar phases forming at pH 
5.1 and above.  The d-spacing and coherence length for CL3 were lower than for the same 
Fig. 24. Effect of temperature and pressure on the coherence length L of sample CL1 
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system at pH 5.1 at the same temperature, also hinting at a potential effect of very high pH 
on the organisation of the lamellar phase of the system. 
 As previously discussed, cardiolipin has been shown to have a significant effect on the 
behaviour of lipid systems47 in vesicles72 and lipid bilayers,61, 62 however no studies examining 
impact on the bulk phase behaviour of model membrane systems could be found.  The finding 
that the presence of cardiolipin has an effect on the behaviour of the system, albeit a small 
one, as well as the finding that pH had a significant impact on the behaviour of the system, 
gives an incentive for further investigation into the role cardiolipin and pH play in shaping the 
phase behaviour of this lipid system. 
Biomembrane models comprising of three of more components can serve as a more 
accurate model for studying the phase behaviour of lipid systems,121 and so additional further 
work following on from this investigation would be the incorporation of additional lipids in 
order to more accurately model the bacterial membrane.  E. coli specifically has been found  
to contain additional lipids beyond PG, PE and CL,55 and contains a range of different lipid 
chain lengths.122  E. coli polar lipid extract and E. coli cardiolipin extract are also available from 
Avanti Polar Lipids,117 both of which contain a range of lipids with differing chain lengths and 
could potentially be used to provide a more accurate model of the behaviour of the E. coli 
membrane. 
The use of buffers that mimic biological conditions such as Phosphate-buffered saline 
may also provide a better model for the behaviour of bacterial membranes in nature, with 
other buffers previously used with similar cardiolipin-containing systems including sodium 
citrate and tris-HCL, and69 HEPES and EDTA123. 
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Chapter 4. Stability of cardiolipin-containing liposomes: Effect of pH 
 
4.1 Abstract 
To further investigate the effects of cardiolipin on the behaviour of a model bacterial 
membrane, liposomes were produced using DOPE/DOPG/CL 70:20:10 and DOPE/DOPG 78:22 
as another model for the bacterial membrane.  In particular, the effects of pH were 
investigated. The liposomes were produced using the extrusion method at pH 5.1 and 12.1, 
and dynamic light scattering (DLS) and zeta potential measurements were used to 
characterise the liposome dispersions over a period of 44 days to assess their stability.  At both 
pH 5.1 and 12.1, no significant change in either the diameter D or the zeta potential ζ was 
observed for the DOPE/DOPG or DOPE/DOPG/CL liposomes over 44 days.  Whilst the average 
ζ potential of the DOPE/DOPG and DOPE/DOPE/CL liposomes were similar at pH 12.1, at pH 
5.1 these values for the DOPE/DOPG liposomes were lower than those for the DOPE/DOPG/CL 
liposomes, with pH having little effect on the ζ of DOPE/DOPG/CL liposomes, pointing to the 
effect of cardiolipin on the structural response to pH of the mixed liposomes.  
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4.2 Results & Discussion 
As well as mesophases, liposomes can also be used as model for the bacterial membrane as 
they mimic the basic structure of a bilayer encapsulating a liquid core, and liposomes with a 
specific composition mimicking a particular membrane can be produced with relative ease.124   
Following on from the HP-SAXS investigation, the effect of cardiolipin and pH on the size, 
stability and zeta potentials of liposomes mimicking bacterial membranes was studied using 
dynamic light scattering (DLS).  The hydrodynamic diameter, reported through DLS, gives the 
diameter of a sphere that would produce the scattering pattern obtained during a 
measurement.  As liposomes are spherical, the reported hydrodynamic diameter is likely to 
closely match the real diameter of the liposomes.  Zeta ζ potential provides a measure of the 
stability of liposomes, as if the ζ potential is low, there will be little repulsion between 
liposomes leading to aggregation due to van der Waals forces.   
The samples prepared used the same compositions as the mesophase samples in 
Chapter 3 (DOPE/DOPG/CL 70:20:10 and DOPE/DOPG 78:22) with DOPE/DOPG samples at pH 
12.1 and 5.1 as controls.  However, it was found during the sample preparation that 
DOPE/DOPG 78:22 and DOPE/DOPG/CL 70:20:10 would not form liposomes at pH 1.3, even 
with additional sonication and vortexing.  Instead, both systems formed a mesophase 
pictured in Fig. 25, which based on the HP-SAXS data collected likely comprised an inverse 
hexagonal HII phase.  Liposomes were successfully formed from DOPE/DOPG 78:22 and 
DOPE/DOPG/CL 70:20:10 mixtures at pH 5.1 and 12.1, confirmed using DLS.  The diameter of 
the liposomes (D) and their zeta potentials (ζ) were then measured over a period of 44 days. 
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4.2.1 Effects of pH and cardiolipin on liposome hydrodynamic diameter 
In Fig. 26, the average diameters D of the DOPE/DOPG and DOPE/DOPG/CL liposomes at pH 
5.1 are compared.  Despite having been extruded using 100 nm-pore membranes, on the day 
of first measurement the average diameter of the liposomes was found to be D = 283.4 nm 
for DOPE/DOPG and 209.00 nm for DOPE/DOPG/CL, which may be due to aggregation of 
liposomes already occurring as observed via PLM in Chapter 5.  While there were changes 
from week-to-week in the average diameter, there was not a large overall change in the 
diameter despite some apparent fluctuations in either sample.   Also present in almost all 
DOPE/DOPG/CL and DOPE/DOPG samples at this pH were larger peaks indicating the 
presence of particles with diameter D over 1000 nm and up to approximately 5400 nm, likely 
 
Fig. 25. The mesophase formed by DOPE/DOPG 78:22 and DOPE/DOPG/CL 70:20:10 at pH 
1.3. 
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caused by a small number of large liposome aggregates.  However, there was some difference 
in the average D of the DOPE/DOPG and DOPE/DOPG/CL across the 47 days, at D = 254.2 nm 
and 191.2 nm respectively.   
Fig. 27. shows the comparison between the average D of DOPE/DOPG and 
DOPE/DOPG/CL liposomes at pH 12.1.  As was the case for these systems at pH 5.1, there was 
little overall change in the average D of the liposomes over time, and large particles of a 
similar size to those in the samples at pH 5.1 were observed, again likely due to larger 
aggregates.  The average D of the DOPE/DOPE/CL liposomes is particularly inconsistent at this 
pH, with relatively large average diameter of 201.9 nm observed at 15 days before returning 
to diameters comparable to the initial average D of 121.3 nm afterwards.  It is possible that 
this large diameter at 15 days is simply due to the particular sample taken on this day.  
Conversely to the liposomes at pH 5.1 (Fig. 26), for these samples at pH 12.1 the average D of  
DOPE/DOPG
78:22
DOPE/DOPG/CL
70:20:10
Fig. 26. Average diameter of DOPE/DOPG (green) and DOPE/DOPG/CL (blue) liposomes at pH 
5.1. 
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the DOPE/DOPG/CL liposomes across all 44 days was larger than the DOPE/DOPG sample, at 
D = 142.7 and 126.7 nm respectively.  
 
4.2.2 Effects of pH and cardiolipin on liposome zeta potential ζ 
In Fig. 28, the zeta potentials of DOPE/DOPG/CL and DOPE/DOPG at pH 5.1 are compared.  
For both samples, the zeta potential ζ was found to be below -30 mV throughout the 44 days 
of measurement, considered to be highly charged particles and indicative of liposome 
stability.125  The average ζ of the DOPE/DOPG liposomes became less negative between 0 and 
6 days from an initial value of ζ = -59.2 mV to a plateau of around ζ = -42 to -43 mV until 
another small increase at 37 days.  Unlike the DOPE/DOPG/CL liposomes, there was an initial 
DOPE/DOPG
78:22
DOPE/DOPG/CL
70:20:10
Fig. 27. Average diameter of DOPE/DOPG (green) and DOPE/DOPG/CL (blue) liposomes at 
pH 12.1 
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decrease in ζ between 0 and 6 days, with notably large decreases at 3 and 6 days.  It is possible 
that these large decreases were due to the particular samples taken on those days rather than 
representing the behaviour of the liposomes on the whole.  The DOPE/DOPG/CL liposomes 
then behaved similarly to the DOPE/DOPG liposomes from 15 days onwards but at more 
negative ζ values of approximately -50 mV until 37 days and a large decrease at 44 days, with 
the ζ of the cardiolipin-containing liposomes remaining consistently lower than the control 
liposomes across the time period studied likely due to the single negative charge cardiolipin 
carries at pH 5.1.  
Fig. 29. shows the average ζ of DOPE/DOPG and DOPE/DOPG/CL liposomes at pH 12.1, 
where cardiolipin carries two negative charges.  As observed at pH 5.1, neither the 
DOPE/DOPG or DOPE/DOPG/CL liposomes underwent a significant change in ζ over the course 
of the 44 days studied, with the charge remaining below -30 mV for both samples indicating 
 
Fig. 28. Average zeta potential ζ of DOPE/DOPG (green) and DOPE/DOPG/CL (blue) liposomes 
at pH 5.1. 
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that they remained stable throughout the time period studied.  In contrast to the 
measurements taken at pH 5.1, there was no difference between the ζ values of the 
DOPE/DOPE or of DOPE/DOPG/CL liposomes.  Another notable difference is that the ζ value 
appeared less stable over time for these samples than for the samples at pH 5.1.  With 
cardiolipin carrying two negative charges at pH 12.1, it is somewhat surprising that a larger 
difference was not observed between the ζ value of the DOPE/DOPG and DOPE/DOPG/CL 
liposomes.  At pH 5.1, the average ζ values across all 44 days were ζ = -44.4 mV and ζ = -55.9 
mV for DOPE/DOPG and DOPE/DOPG/CL, respectively, whereas they were ζ = -61.9 mV and ζ 
= -56.4 mV for DOPE/DOPG and DOPE/DOPG/CL at pH 12.1.  Thus, it is seen that the change 
in pH from 5.1 to 12.1 had little effect on the charge and stability of the DOPE/DOPG/CL 
liposomes, while actually having a larger effect on the DOPE/DOPG liposomes, which were 
more highly charged and stable at pH 12.1.  
Fig. 29. Average zeta potential ζ of DOPE/DOPG (green) and DOPE/DOPG/CL (blue) 
liposomes at pH 12.1. 
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4.2.3 Effects of pH and cardiolipin on polydispersity index (PDI) of liposomes 
The polydispersity index (PDI) is a measure of the size distribution of particles in a solution, 
with a high PDI indicating a highly polydisperse solution with a range of different particles 
sizes present, while a low PDI indicates a monodisperse sample where all particles are the 
same size.  PDI values below 0.05 are considered to be monodisperse, while values of 0.7 and 
above indicate a broad range of different particle sizes, i.e. a very polydisperse sample, 
however PDI values of 0.3 and below are considered acceptable for liposomes used in drug-
delivery applications.126 
Fig. 30. Shows how the polydispersity index (PDI) of DOPE/DOPG liposomes at pH 5.1 
changed over time.  There was a higher initial PDI of 0.469 before dropping below 0.4 after 
24 hours and remaining below 0.4 for the remaining time studied.  There was an increase in 
PDI between 7 and 22 days with a peak at 0.370 before another drop. However, this apparent 
 
Fig. 30. Polydispersity index (PDI) of DOPE/DOPG liposomes at pH 5.1. 
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instability in PDI was likely due to different samples taken on different days.  There were large 
particles likely arising from large aggregated present in small numbers.  As no large or 
persistent change in PDI was observed across the 44 days, it is likely that any aggregation or  
changes in the composition of the sample were minimal. 
Fig. 31. Shows the PDI of DOPE/DOPG/CL at pH 5.1 over time.  As with DOPE/DOPG at 
this pH, the PDI saw a decrease from 0.317 to 0.135 at 15 days, before increasing to 0.388 at 
37 days and then returning to a PDI similar to the initial value of 0.305.  This sample also 
showed instability in PDI, again likely resulting from difference in individual samples and 
aggregation.  One notable difference between DOPE/DOPG/CL at pH 5.1 and DOPE/DOPG is 
that the average PDI across 44 days for DOPE/DOPG/CL was 0.279 compared to 0.347 for 
DOPE/DOPG.  Although repetition would be needed to confirm the difference observed and  
whether the presence of cardiolipin has an effect on PDI.  
 
Fig. 31.  Polydispersity index (PDI) of DOPE/DOPG/CL liposomes at pH 5.1. 
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 In Fig. 32, the PDI of DOPE/DOPG liposomes at pH 12.1.  In contrast to the same system 
at pH 5.1, there was a large increase in PDI from a lower initial value of 0.211 to 0.401 at 4 
days.  The PDI was similarly unstable across the 44 days, returning to values comparable to 
the initial value of 0.213 and 0.206 at 15 and 37 days.  As with the previous samples, this 
instability is likely due to sample differences and the presence of aggregated.  The average 
PDI value across the 44 days was 0.288, lower than the average value of 0.347 for DOPE/DOPG 
at pH 5.1 and closer to the average PDI for DOPE/DOPG/CL at pH 5.1 of 0.279. 
In Fig. 33. The PDI of DOPE/DOPG/CL at pH 12.1 are shown, and as with the previous 
samples the PDI appeared to be unstable, assumed to be for the same reasons as the other 
samples.  However, for this sample the initial PDI was comparatively low at 0.114, before 
Fig. 32. Polydispersity index (PDI) of DOPE/DOPG liposomes at pH 12.1. 
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increasing to values comparable to those obtained for the other samples.  The average PDI 
across the 44 days was 0.249, the lowest of the four samples.   
 
 
4.3 Conclusions 
In summary, the average hydrodynamic D of both DOPE/DOPG and DOPE/DOPG/CL 
liposomes were smaller at pH 12.1 than at pH 5.1, as summarised in Table 4.  No clear trends 
in the hydrodynamic diameter over time were observed; however, differences in the average 
D of the samples were observed.  As the charge of cardiolipin varies with pH (figure 34)127, 
this may have played a role in the average D values of the different samples.  Cardiolipin is 
known to promote and stabilise negative curvature by segregating into the inner leaflet of  
 
Fig. 33. Polydispersity index (PDI) of DOPE/DOPG/CL liposomes at pH 12.1. 
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bilayers,128 and it is possible that cardiolipin played a role in stabilising smaller liposomes  with 
a larger curvature at pH 5.1 where it carries a single negative charge.  Compared to the 
DOPE/DOPG liposomes, the DOPE/DOPG/CL liposomes underwent a smaller reduction in the 
average D between pH 5.1 and 12.1.  This smaller negative curvature may again be explained 
by cardiolipin’s pH-responsiveness, as at pH 12.1 it carries two negative charges and 
headgroup repulsion is at a maximum, potentially decreasing cardiolipin’s propensity towards 
negative curvature.   
The ζ measurements showed that, while both systems at both pH values studied 
produced moderately charged and therefore stable liposomes with ζ values averaging below 
-30 mV, pH had a different effect on the DOPE/DOPG and DOPE/DOPG/CL liposomes.  At pH 
Lipid Composition pH Average D / nm Average ζ / mV Average PDI 
 
DOPE/DOPG 
5.1 254.2 -44.1 0.347 
12.1 126.7 -61.9 0.288 
 
DOPE/DOPG/CL 
5.1 191.2 -55.9 0.279 
12.1 142.7 -56.4 0.249 
Table 4. summary of DLS results 
 
Fig. 34. Different behaviours of cardiolipin at the two pH values examined.  Adapted 
from reference 123 
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5.1, DOPE has no charge, whereas DOPG129 and cardiolipin both carry a single negative charge.  
At pH 5.1, the DOPE/DOPG/CL liposomes had a larger charge than the DOPE/DOPG liposomes, 
owing to the additional negative charge from the cardiolipin present. 
At pH 12.1 where cardiolipin has an even greater negative charge of -2, unexpectedly 
it was the DOPE/DOPG liposomes which had a lower average ζ value.  A drop in ζ at lower pH 
was expected for both lipid compositions as pH greatly influences ζ. However, pH appeared 
to have little effect at all on the ζ values of the DOPE/DOPG/CL liposomes, with ζ = -55.85 mV 
at pH 5.1 and ζ = -56.43 mV at pH 12.1.  The PDI values for the samples also showed little 
change over time with the exception of the DOPE/DOPG/CL liposomes at pH 12.1 where an 
increase from the initial PDI was observed.  It would be expected that because these samples 
all had a large negative ζ indicating stability, the PDI values obtained would also be low due 
to the low amount of aggregation that would be expected with this stability.  The largest 
average PDI of 0.347 was obtained for DOPE/DOPG liposomes at pH 5.1, which also had the 
smallest average ζ, in agreement with expectations that a smaller ζ would lead to more 
aggregation.  The average PDI was also lower for the DOPE/DOPG/CL liposomes at both pH 
values, potentially pointing to cardiolipin reducing the amount of aggregation due to the 
additional charge it confers, but additional DLS measurements would need to be carried out 
to confirm this. 
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Chapter 5. Polarised light microscopy (PLM) images of bacterial 
membrane mimics 
 
 
5.1 Abstract 
To complement the HP-SAXS data, polarised light microscopy (PLM) images of DOPE/DOPG 
78:22 and DOPE/DOPG/CL 70:20:10 were obtained at pH 1.3, 5.1 and 12.1.  Control PLM 
images were also obtained for pure DOPG and pure cardiolipin at pH 1.3, 5.1 and 12.1.  It was 
found that the PLM images for both bacterial membrane mimic systems showed a clear 
difference in behaviour between pH 1.3, and pH 5.1 and 12.1.  This is consistent with the HP-
SAXS data showing a difference in phase behaviour at pH 1.3 for both DOPE/DOPG and 
DOPE/DOPG/CL.  Liposomes and their aggregates were observed in the samples, also 
consistent with the HP-SAXS data from these samples.  In addition, pure cardiolipin and pure 
DOPG samples were found to behave differently at pH 1.3 than at higher pH values, 
highlighting the important role of pH in determining the phase behaviour of these lipids and 
lipid systems. 
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5.2 Results & discussion 
Polarised light microscopy (PLM) is an optical technique that can be used to identify 
mesophases, which exhibit different visible textures with polarised light.130 Other structures 
such as liposomes in samples can also be visually identified.  It is particularly useful in 
conjunction with SAXS for phase characterisation and thus chosen in this project, supporting 
the phase assignment from SAXS peaks.  DOPE/DOPG 78:22 and DOPE/DOPG/CL 70:20:10 
mesophases at pH 1.3, 5.1 and 12.1 were prepared following the same method as that of the 
HP-SAXS samples.  In addition, pure DOPG and CL mesophases were examined using PLM for 
comparison.  
 
 
Fig. 35. PLM images of pure cardiolipin at pH 1.3 taken with a 530 nm waveplate inserted, at 
10x magnification.  White arrow indicates striation. 
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5.2.1 Individual lipids 
PLM images of pure cardiolipin at pH 1.3, 5.1 and 12.1 were obtained in order to compare the 
behaviour of cardiolipin alone with DOPE/DOPG and with DOPE/DOPG/CL.  Fig. 35. shows 
cardiolipin at pH 1.3, displaying a texture similar to that observed in DOPE/DOPG and 
DOPE/DOPG/CL at pH 1.3, suggesting that pure cardiolipin also forms the HII phase at pH 1.3.  
Some striation was also observed (indicated by white arrow in Fig. 34. C), which is also 
observed in HII phases.130  Cardiolipin has a propensity towards forming the HII phase due to 
its >1 packing parameter, particularly at low pH where the repulsion between the two 
headgroups is minimised.   
 
 
Fig. 36.  PLM images of pure cardiolipin at pH 5.1 taken with a 530 nm waveplate inserted, 
at 10x magnification.  White arrow indicates striation, green arrow indicates a liposome. 
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In Fig. 36, PLM images of pure cardiolipin at pH 5.1 are shown.  For this sample, it is 
less clear what phase the cardiolipin has formed. Due to issues with the sample drying quickly 
on the slide, it is unclear if these images accurately represent the behaviour of pure cardiolipin 
in a hydrated mesophase as was the case for the HP-SAXS samples. Despite this, there are still 
some notable features of interest including striations as indicated in Fig. 36. A which could 
result from either a HII or lamellar phase, and a small number of liposomes as indicated in Fig. 
36. D.  
 
 
Fig. 37.  PLM images of pure cardiolipin at pH 12.1 taken with a 530 nm waveplate inserted, 
at 10x magnification.  The white arrow indicates striation, the green arrow indicates a 
liposome and the blue arrow indicates an air bubble. 
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Fig. 37. Shows that the PLM images for pure cardiolipin at pH 12.1 were very similar 
to pure cardiolipin at pH 5.1, also containing a small number of small liposomes, patches of  
birefringent mesophase and striations as indicated by arrows in Fig. 37. A & B.  It is notable 
that this sample and pure cardiolipin at pH 5.1 have a very different texture to pure cardiolipin 
at pH 1.3, indicating that the cardiolipin is likely at least partially in a different phase (the HII 
phase) at pH 1.3.  Also notable is the presence of liposomes at pH 5.1 and 12.1, but not at 1.3.  
PLM images were also taken for pure DOPG at pH 1.3 as shown in Fig. 37.  As with pure 
cardiolipin at pH 5.1 and 12.1, this sample suffered from the issue of drying rapidly; however, 
comparisons can still be made with pure cardiolipin at pH 1.3.  Liposomes were present in this 
sample (Fig. 38. C), as well as birefringent mesophases (Fig. 38. A & B),  
 
 
Fig. 38.  PLM images of pure DOPG at pH 1.3 taken at different locations (A & C) with a 530 
nm waveplate inserted, at 10x magnification.  The green arrow indicates a liposome. 
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although it is unclear what phase(s) were present and HP-SAXS measurements would be 
required to identify this accurately.                    
The striations in Fig. 39. A indicate the presence of a lamellar phase, with liposomes 
also observed as shown in Fig. 39. B.  This is similar to the results obtained for both 
DOPE/DOPG and DOPE/DOPG/CL at this pH, suggesting that similar HP-SAXS results may be 
obtained for pure DOPG at this pH.  This would not be surprising given the fact that 
 
 
Fig. 39.  PLM images of pure DOPG at pH 5.1 taken with a 530 nm waveplate inserted, at 
10x magnification.  The green arrow indicates a liposome. 
 
 
Fig. 40.  PLM image of pure DOPG at pH 12.1 taken with a 530 nm waveplate inserted at 10x 
magnification. 
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DOPE/DOPG alone formed a lamellar phase with liposomes.  Some liposome aggregation was 
also observed in this sample (Fig. 39. B). 
Finally, pure DOPG at pH 12.1 was also examined via PLM (Fig. 40).  Notable in this 
sample was the large number of liposomes and their aggregation, and apparent lack of 
birefringent mesophase. 
 
 
5.2.2 Lipid systems 
 
 
Fig. 41.  PLM images of DOPE/DOPG at pH 1.3 taken with a 530 nm waveplate inserted, at 
4x magnification (A, B), 10x magnification (C) and 20x magnification (D).  Example of 
striations indicated with yellow arrow. 
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Fig. 41. and Fig. 42. Show PLM images of DOPE/DOPG and DOPE/DOPG/CL samples, 
respectively, at pH 1.3.  At this pH, DOPE/DOPG/CL was found to be in the inverse hexagonal 
HII phase via HP-SAXS.  The images obtained are dark due to the thickness and viscosity of the 
mesophase samples used, this viscosity being characteristic of the presence of the HII 
phase.130 Both images are noticeably different in texture and appearance from the samples 
prepared at pH 5.1 and 12.1 (Fig. 43-46).  Yellow arrows in Fig. 41 B and Fig. 42 B have been 
used to indicate the presence of striations in both samples, which is indicative of the HII phase 
and observed with other lipids in this phase;131, 132 at higher magnifications for DOPE/DOPG, 
a fan- like texture is visible which is also characteristic of the HII phase.133  The PLM images for 
these samples are thus supportive of the assignment of the HII phase to the HP-SAXS 
measurements of the DOPE/DOPG/CL sample at p = 0-3000 bar and T = 45 & 60°C, p = 1-2400 
bar at T = 30°C, and p = 1-1800 bar at T = 20°C (Fig. 41. A), and also suggest that an HP-SAXS 
measurement of DOPE/DOPG alone at this pH would show the presence of a HII phase under 
ambient conditions.   No evidence of the presence of any liposomes was found for these 
samples using PLM, in agreement with the HP-SAXS measurements taken. 
DOPE/DOPG/CL 70:20:10, T = RT, pH = 1.3 
A B 
Fig. 42. PLM images of DOPE/DOPG/CL at pH 1.3 taken with a 530 nm waveplate inserted at 
4x magnification.  Example of striation indicated with yellow arrow. 
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Fig. 43. shows PLM images for the DOPE/DOPG sample at pH 5.1.  In agreement with 
the HP-SAXS measurements for this sample, both mesophases and vesicles were present in 
this sample, with some vesicles such as the one indicated in Fig 43. A & C being approximately 
36 μm in diameter - very large and likely a multilamellar vesicle, while others such as the one 
indicated in Fig. 43. D are far smaller.  An aggregate of liposomes is also visible in Fig. 43. C.  
The mesophase observed resembles lamellar phases observed previously in literature134 
supporting the assignment of an Lα phase to the HP-SAXS data for this sample under ambient 
 
Fig. 43.  PLM images of DOPE/DOPG at pH 5.1 taken with a 530 nm waveplate inserted, at 
4x magnification (A & B) and 10x magnification (C & D).  Green arrows indicate examples of 
vesicles in the samples, orange arrow indicates oily streak texture, and blue arrows indicate 
air bubbles. 
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conditions. The ‘oily streaks’ texture observed in Fig. 43. A & C (orange arrow) is often 
observed in lamellar phases.135 
Fig. 44 shows DOPE/DOPG/CL at pH 5.1.  No very large vesicles such as the one present 
in the DOPE/DOPG sample (Fig. 43) were observed in this sample, but smaller vesicles as 
indicated with the green arrow in Fig. 44. B were present, as predicted from the HP-SAXS 
results.  In Fig. 44. A in bright blue, striations typical of a lamellar phase are present,132, 136 in 
further support of the assignment of this phase to the HP-SAXS data.  In Fig. 44. A and Fig. 44. 
 
 
Fig. 44.  PLM images of DOPE/DOPG/CL at pH 5.1 taken with a 530 nm waveplate inserted, 
at 4x magnification (A&B) and 10x magnification (C).  The green arrow indicates an example 
of vesicles in the sample, and the blue arrow indicates an air bubble. 
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C (a higher magnification image of the central birefringent area) an oily streaks texture similar 
to that observed in DOPE/DOPG is present, again likely a lamellar phase.  
 
Fig. 45. shows DOPE/DOPG at pH 12.1.  As with the samples at pH 5.1, vesicles were 
present of a similar size to the small ones observed in these samples, with no very large 
vesicles resembling the one in DOPE/DOPG observed (Fig. 43).  There were fewer areas of 
birefringence observed in this sample, although some small areas of striations characteristic 
of a lamellar phase were observed (indicated by yellow arrows in Fig. 45).  HP-SAXS data was 
not obtained for this sample. However, this combination of lamellar phase and vesicles was 
observed via HP-SAXS for DOPE/DOPG/CL at this pH, and so this suggests that HP-SAXS 
measurements of this sample may be similar. 
Fig. 46. shows DOPE/DOPG/CL at pH 12.1, and in agreement with the HP-SAXS data 
for this sample, both vesicles and striations indicating the presence of the lamellar phases 
identified via HP-SAXS, and similarly to both samples at pH 5.1 and DOPE/DOPG at pH 12.1 
(Fig. 43, 44 & 45).  A noticeable difference with DOPE/DOPG at pH 12.1 is the much larger 
 
Fig. 45.  PLM images of DOPE/DOPG at pH 12.1 taken with a 530 nm waveplate inserted, at 
4x magnification (top row) and 10x magnification (bottom row).Green arrows indicate 
examples of vesicles in the sample, yellow arrow indicates striation typical of lamellar phase. 
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prevalence of birefringent mesophase and the greater number of vesicles observed in the 
sample.  It is possible that this difference is due to the presence of cardiolipin, and a 
comparison with DOPE/DOPG at pH 12.1 via HP-SAXS would shed light on whether this is a  
significant difference between the two samples.  
 
5.3 Conclusions 
The PLM images taken for the samples studied via HP-SAXS (DOPE/DOPG at pH 5.1, and 
DOPE/DOPG/CL at pH 1.3, 5.1 and 12.1) all appear to support the phase assignment in chapter 
 
Fig. 46.  PLM images of DOPE/DOPG/CL at pH 12.1 taken with a 530 nm waveplate inserted, 
at 4x magnification (A, B & C) and 10x magnification (D).  Green arrows indicate examples of 
vesicles in the sample, yellow arrow indicates striation typical of the lamellar phase, blue 
arrow indicates example of air bubble in the sample. 
99 
 
3 from the HP-SAXS data, summarised in table 5, as well as showing the liposomes responsible 
for the shape of the HP-SAXS graphs.  
 The PLM images for DOPE/DOPG at pH 1.3 (Fig. 41) and 12.1 (Fig. 42) suggest that the 
behaviour of this system is likely similar to the behaviour of DOPE/DOPG/CL at these pH 
values (Fig. 41 & 46), forming an HII phase at low pH and a lamellar phase with liposomes at  
 pH 12.1. DOPE forms the HII phase under ambient conditions,96, 137 but as also observed via 
HP-SAXS in chapter 3, the addition of DOPG resulted in the formation of a lamellar phase 
instead, in line with the finding of Morein et al. that DOPE/DOPG in a 7:3 ratio forms the Lα 
phase at pH 7.4.116  This again indicates that the DOPG played some role in changing the 
spontaneous curvature of the lipid system at pH 5.1, possibly by increasing lateral pressure 
between the headgroups present without increasing the lateral pressure between the tail 
groups, as DOPE and DOPG have identical tail groups.  The PLM results showing an HII phase 
at pH 1.3 for DOPE/DOPG (Fig. 41) indicate that the same phase behaviour occurs in 
DOPE/DOPG without the presence of cardiolipin, i.e. DOPE and DOPG are also responding to 
pH.  A possible reason for this is that the phosphate headgroups of DOPE and DOPG are likely 
Lipid composition pH Phase 
DOPE/DOPG 78:22 1.3 HII 
DOPE/DOPG 78:22 5.1 Lamellar 
DOPE/DOPG 78:22 12.1 Lamellar 
DOPE/DOPG/CL 70:20:10 1.3 HII 
DOPE/DOPG/CL 70:20:10 5.1 Lamellar 
DOPE/DOPG/CL 70:20:10 12.1 Lamellar 
Table 5. Phase assignment of lipid samples observed via PLM 
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also being protonated at very low pH, producing the same effect observed with cardiolipin 
wherein a greater negative curvature is favoured. 
Comparing the DOPE/DOPG and DOPE/DOPG/CL samples (Fig. 41-46) to the pure lipid 
samples (Fig. 35-40), the behaviour of the mixed lipid systems more closely mirrored the 
behaviour of pure cardiolipin than pure DOPG, with an HII phase at pH 1.3 and lamellar phases 
with liposomes at pH 5.1 and 12.1 for both pure cardiolipin and DOPE/DOPG/CL.  DOPG alone 
on the other hand had liposomes present at all pH values studied and did not have a clear 
phase difference between pH 1.3 and pH 5.1.  As previously discussed, at pH 12.1 the 
repulsion between cardiolipin’s two headgroups is greatest as it carries two negative charges, 
while  at pH 1.3 the repulsion is minimal as the headgroup carries no charge, and so it was 
predicted that the HII phase would be observed at low pH for these samples due to 
cardiolipin’s greater packing parameter and thus it’s greater propensity for negative 
curvature. 
These PLM results all highlight the large role pH appears to play in the phase behaviour 
of these lipids, supporting especially the large differences in behaviour at low pH of these 
systems also observed via HP-SAXS. 
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Chapter 6. Conclusions & Future Work 
 
Cardiolipin is a unique four-tailed pH-responsive phospholipid found in the membranes of 
bacteria, contributing to maintaining the membrane properties in various ways such as 
increasing propensity for negative curvature and increasing lateral pressure within the 
membrane.  Understanding its role in shaping the properties of bacterial membrane 
mimics will contribute towards a better understanding of the ways in which bacteria adapt 
and respond to their environment and therefore may assist in finding new ways to combat 
them.  
pH was found to play a major role in the phase behaviour of 
DOPE/DOPG/CL mesophases used as bacterial membrane mimics though the use of HP-
SAXS.  At pH 1.3, the system formed an HII phase under ambient conditions, while under the 
same conditions at pH 5.1 and 12.1 an Lα phase formed.  Without control samples at pH 1.3 
and 12.1, it is unclear the extent to which this phase behaviour was due to the presence of 
cardiolipin, but it is clear that the system was pH-responsive.  Both the d-spacing and 
coherence length of the system were lower at pH 12.1 than at pH 5.1 under the same 
conditions, demonstrating that the system was responsive to both low and high pH.    
As well as the effect of pH, the effect of cardiolipin on the behaviour of the system at 
pH 5.1 was observed, with cardiolipin lowering the pressure required to induce the 
Lα → Lβ phase transition at 20°C that was observed in the samples at pH 5.1 and 12.1 by 
approximately 300 bar, likely due to the increased lateral pressure introduced by cardiolipin’s 
bulky chains.  Cardiolipin also increased the d-spacing observed at pH 5.1 and increased the 
sensitivity of the coherence length to temperature changes.  Additionally, as expected, the 
system was found to respond to temperature with the Lβ phase only appearing at T = 20 and 
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25°C, as at higher temperatures, the lateral pressure between the tail groups was too great 
for the transition to occur in the pressure range studied.   
These results were supported by PLM images taken of DOPE/DOPG and 
DOPE/DOPG/CL mesophases, with images of DOPE/DOPG controls taken at pH 1.3 and 12.1 
as well as at pH 5.1, providing additional information on the effects of cardiolipin on the 
system at these pH values not obtained via HP-SAXS.  It was found that the DOPE/DOPG 
controls exhibited the same phase behaviour as the DOPE/DOPG/CL samples at all three pH 
values studied, indicating that cardiolipin did not have a significant effect on the phase 
behaviour of the system and its role was likely more subtle.  The PLM images also confirmed 
the presence of liposomes within all of the samples at pH 5.1 and 12.1, evident from the HP-
SAXS data.  In addition to the mixed lipid systems, individual DOPG and 
cardiolipin systems were examined for comparison.  Although rapid sample drying 
prevented the clear assignment of phases to many of these samples, a clear difference in 
morphology was observed between cardiolipin at pH 1.3, and cardiolipin at pH 5.1 and 12.1, 
suggesting that it may have similar phase behaviour to the lipid systems 
examined.  Meanwhile, there was no clear phase difference between pH 1.3 and 1.5 for 
DOPG.  
The effects of pH and cardiolipin on the stability of DOPE/DOPG and 
DOPE/DOPG/CL liposomes used as bacterial membrane mimics were also investigated using 
DLS.  Although only two pH values were investigated as liposomes would not form at pH 
1.3, both pH and cardiolipin were found to have an effect on the stability and the average 
diameter of the liposomes.  While there was no overall change in the 
average diameter D or the zeta potential ζ over time, the DOPE/DOPG liposomes showed a 
much larger decrease in both the D, ζ and polydispersity (PDI) of the liposomes at pH 12.1 
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compared to pH 5.1, while the DOPE/DOPG/CL liposomes showed only a small decrease.  This 
points to cardiolipin somewhat moderating the effects of high pH on 
the size, charge, and aggregation of the liposomes. In the context of bacterial membranes, 
this implies that cardiolipin could function to moderate the pH variations in the surrounding, 
thereby reducing its sensitivity pH changes and enhancing the robustness and stability of the 
bacteria membrane.   
In summary, the DOPE/DOPG and DOPE/DOPG/CL bacterial membrane mimic 
systems were found to be pH responsive, and the presence of cardiolipin caused subtle 
differences in the phase behaviour, d-spacing and coherence length - all affected by the 
presence of cardiolipin at pH 5.1.  DOPG/DOPG liposomes were also found to behave 
differently at pH 12.1 than at pH 5.1, with a greater ζ and smaller D, while DOPE/DOPG/CL 
liposomes were not very responsive to an increase in pH.  These observed 
effects provided justification for further investigation into the role cardiolipin and pH play in 
shaping the behaviour of bacterial membrane mimic systems.  
On the basis of the HP-SAXS results obtained, a successful proposal was submitted for 
beamtime at Diamond I22, and further HP-SAXS measurements were obtained for this system 
in February 2020.  Part of the future work for this project will be to fully analyse this data, 
as data for DOPE/DOPG controls at pH 1.3 and 12.1 as well as were obtained, thereby 
completing the original set of measurements for the project and allowing for the role of 
cardiolipin in the system’s response to low and high pH to be assessed.  In addition to the 
original three pH values measured, measurements were taken of DOPE/DOPG and 
DOPE/DOPG/CL at pH 2.0, 3.0 and 4.0 were obtained in order to more ascertain more 
precisely the pH at which the system transitions from forming the HII phase to the Lα phase 
under ambient conditions.  Repeat measurements were also obtained for the temperature-
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pressure phase diagrams already produced, at an extended pressure range (1-3600 bar) 
to better observe the Lα -> Lβ phase transition.  This pressure range was also used for the new 
pH values.  In addition, a sample with a new composition (DOPE/DOPG/CL 62:18:20) was 
measured at pH 5.1 in order to study if increasing the proportion of cardiolipin in the 
system exaggerated the effects of cardiolipin previously observed, as well as pure cardiolipin 
at pH 5.1 for comparison.  
The bacterial membrane is a complex structure, and so biomembrane models 
comprising of three or more components can serve as a more accurate model for studying 
the phase behaviour of lipid systems.1  The incorporation of additional lipids into mesophases 
would provide better insight into the behaviour of a real bacterial membrane, and E. 
coli specifically (which was mimicked in this work) has been found to contain additional lipids 
beyond PG, PE and CL,2 of varying chain lengths.  E. coli polar lipid extract and E. 
coli cardiolipin extract are available from Avanti Polar Lipids,3, 4 both of which contain a range 
of lipids with differing chain lengths and could be used to provide a more accurate model of 
the behaviour of the E. coli membrane.  Further studies using liposomes as a model for the E. 
coli membrane could incorporate other bacterial membrane components such as 
lipopolysaccharide (LPS) which is found in the outer leaflet of gram negative bacteria.5  The 
use of buffers that mimic biological conditions such as phosphate-buffered saline may also 
provide a better model for the behaviour of bacterial membranes in nature, with other 
buffers previously used with similar cardiolipin-containing systems including sodium citrate 
and tris-HCL, and6 HEPES and EDTA7.    
In addition to changes to the bacterial membrane model itself, the system could be 
investigated further by extending the HP-SAXS pressure-temperature phase diagrams for the 
samples to higher pressures and lower temperatures to better observe the Lα → 
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Lβ phase boundary, as well as using smaller temperature and pressure steps to better observe 
mixed phase regions.  Obtaining pressure-temperature phase diagrams for pure DOPE, 
DOPG and 18:1 cardiolipin at pH 1.3, 5.1 and 12.1 would provide a useful comparison for the 
behaviour of the lipid systems.  More insight into the effect of cardiolipin on the 
system would also be gained by investigating a mesophase consisting of only DOPE and 
cardiolipin, to be compared with the DOPE/DOPG mesophase and a pure DOPE pressure-
temperature phase diagram, and PLM images of these samples could be obtained to support 
phase assignment.  
The effect of the presence of biologically relevant ions such as 
Na+, K+, and Ca2+,  which have been found to play a role in the stability of liposomes,8, 9 would 
also be interesting to investigate.  Further insight into the role cardiolipin plays in the 
bacterial membrane and its response to the bacterium’s external environment could be 
obtained by investigating the effects of biologically relevant ions on the properties 
of cardiolipin-containing liposomes through D, PDI and ζ measurements over time.  
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